+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 32784

Chapter 32784 contains a list of PDF Full Texts available from EurekaMag.

Marin, G.H.; Porto, A.; Prates, V.; Napal, J.; Bordone, J.; Etchegoyen, O.; Castelleto, R.; Morales, V.; Milone, J., 1997:
Pharmacological induction of graft versus host disease in autologous stem cell transplantation

Saporito, M.S.; Wilcox, H.M.; Hartpence, K.C.; Lewis, M.E.; Vaught, J.L.; Carswell, S., 1993:
Pharmacological induction of nerve growth factor mRNA in adult rat brain

Steinmeyer, J.; Kim, C.; Sadowski, T.; Kalbhen, D.A., 1996:
Pharmacological influence of the activity of plasmin and plasminogen activators in vitro

Steinmeyer, J.; Daufeldt, S.; Kalbhen, D.A., 1994:
Pharmacological influence on activity of the metalloproteinase stromelysin from articular cartilage

Steinmeyer, J.; Burton Wurster, N.; Lust, G., 1992:
Pharmacological influence on fibronectin and keratan sulfate synthesis by cultured canine articular cartilage chondrocytes

Glusa, E., 1995:
Pharmacological influence on vascular thrombin effects

Zhang, Y.; Seibert, K.; Hauser, S.; Gregory, S.; Isakson, P., 1994:
Pharmacological inhibition of COX-2 prevents eicosanoid production and edema in vivo

Ozdemir, S.; Bito, V.; Holemans, P.; Vinet, L.; Mercadier, J-Jacques.; Varro, A.; Sipido, K.R., 2008:
Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block

Bucala, R.; Vlassara, H., 1994:
Pharmacological inhibition of advanced glycosylation Prospects for the treatment of diabetic vascular disease

Papatheofanis, F.J.; Shirazi, P.; Henkin, R.E., 1995:
Pharmacological inhibition of aerosolized DTPA-stimulated prostaglandin and cytokine release from polymorphonuclear leukocytes

Oyarzun, M.J.; Dussaubat, N.; Capetillo, M.; Rocco, V.; Mendoza, R.; Lathrop, M.E., 1995:
Pharmacological inhibition of bleomycin-induced pulmonary fibrosis in the rat

Luescher, T.F.; Wenzel, R.R.; Noll, G., 1995:
Pharmacological inhibition of endothelin-induced vasoconstriction in man Focus on calcium channel blockers and endothelin receptor antagonists

Inagaki, K.; Koyanagi, T.; Berry, N.C.; Sun, L.; Mochly-Rosen, D., 2008:
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure

Demas, G.E.; Eliasson, M.J.L.; Kriegsfeld, L.J.; Dawson, T.M.; Dawson, V.L.; Nelson, R.J.; Snyder, S.H., 1997:
Pharmacological inhibition of neuronal nitric oxide synthase increases aggressive behavior in male mice

Kroemer, G.; Martínez, C., 1994:
Pharmacological inhibition of programmed lymphocyte death

Shaw, L.A.; Rudin, M.; Cook, N.S., 1995:
Pharmacological inhibition of restenosis: learning from experience

Fischell, T.A.; Kaplan, A.V.; Leung, L.L K., 1991:
Pharmacological inhibition of subendothelial platelet deposition after arterial injury

Sorota, S., 1993:
Pharmacological inhibition of the swelling-induced chloride-sensitive current in dog atrial cells

Borchard, U.; Berger, F.; Hafner, D.; Kammer, T., 1989:
Pharmacological inhibition of transient outward current correlates with action potential prolongation in sheep cardiac purkinje fibers

Horiguchi, A.; Asano, T.; Asano, T.; Ito, K.; Sumitomo, M.; Hayakawa, M., 2008:
Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells

Netea, G.; Blok, W.L.; Kullberg, B.J.; Van Der Meer, J.W.M., 1994:
Pharmacological inhibitors of tumor necrosis factor alpha production exert differential effects in endotoxic shock and in infection with live microorganisms in mice

Kittila, C.A.; Massey, S.C., 1996:
Pharmacological inputs to directionally selective retinal ganglion cells in rabbit

Iyaniwura, T.T., 1989:
Pharmacological interaction and combined toxicity of exposure to environmental chemicals

Mezick, J.A.; Gendimenico, G.J.; Perlin, A.J.; Rosenthale, M.E.; Capetola, R.J., 1990:
Pharmacological interactions between glucocorticoids and retinoids in mouse skin

Jones, G.H.; Huth, A.; Ottow, E.; Turski, L., 1995:
Pharmacological interactions of the AMPA antagonist NBQX with CNS depressants

Schwarcz, R.; Guidetti, P.; Ceresoli, G.; Lee, S.C.; Wu, H.O.; Varasi, M.; Speciale, C., 1997:
Pharmacological interference with kynurenine pathway metabolism in the rat Effects of kynurenine metabolites in blood and brain

Dulcan, Mina, K., 1994:
Pharmacological intervention

Tiegs, G., 1990:
Pharmacological intervention against tnf alpha induced hepatitis in d galactosamine sensitized mice

Miller, N.E., 1990:
Pharmacological intervention for altering lipid metabolism

Yanagishita, T.; Matsuoka, T.; Kako, K.J., 1989:
Pharmacological intervention in calcium pump dysfunction induced by leukocyte derived oxidants

Nowak, G.; Bucha, E., 1997:
Pharmacological intervention in experimental endotoxin shock-induced cardiac dysfunction

Edwardson, J.M.; Daniels, P.U.; Nadin, C.Y., 1989:
Pharmacological intervention in golgi function in mdck cells

Mathison, Y.; Roa, E.; Mendible, A.; Gomez, N.; Williams, P.; Vargas, E.; Meneses, P., 1996:
Pharmacological intervention in hyperlipidaemic children Use of L-carnitine

Bendtsen, P.; Akerlind, I.; Hörnquist, J.O., 1995:
Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects

Jugdutt, B.I., 1996:
Pharmacological intervention in post-infarction wound healing

Miller, J.D., 1992:
Pharmacological intervention in sleep and circadian processes

Geshi, E.; Konno, N.; Ito, S.; Mukae, S.; Suwa, Y.; Hiroshige, J.; Hasegawa, S.; Umetsu, K.; Mochizuki, M.; E.A., 1989:
Pharmacological intervention of acute ischemic myocardial injury

Fellstrom, B., 1992:
Pharmacological intervention of chronic graft rejection

Yamamoto, F.; Yamamoto, H.; Yoshida, S.; Ichikawa, H.; Komai, H.; Ohashi, T.; Koide, A.; Kosakai, Y.; Yagihara, T.; E.A., 1990:
Pharmacological intervention of ischemia reperfusion injury

Nolte, D.; Lehr, H.A.; Menger, M.D.; Messmer, K., 1992:
Pharmacological intervention of postischemic leukocyte endothelium interaction in striated muscle

Jansen, J.W.C.M., 1990:
Pharmacological intervention of the fibrinolytic system

Nirala, S.Kumar.; Bhadauria, M.; Shukla, S.; Agrawal, O.Prakash.; Mathur, A.; Li, P.Qiang.; Mathur, R., 2008:
Pharmacological intervention of tiferron and propolis to alleviate beryllium-induced hepatorenal toxicity

Wendel, A.; Tiegs, G., 1993:
Pharmacological intervention studies against lipopolysaccharides or TNF-alpha toxicity in mice

Berwick, J.; Versnel, H.; Coffey, P.; Mayhew, J., 1998:
Pharmacological intervention to reduce vascular noise in intrinsic optical imaging of rat barrel cortex and ferret auditory cortex

Lijnen, P., 1989:
Pharmacological intervention trials in elderly hypertensives

Wilson, J.R.; Mancini, D.M., 1992:
Pharmacological interventions can acutely improve exercise capacity in patients with heart failure

Wetherby, M.M.C.; Cheong, J.A.; Evans, D.L.; Schmitt, F.A., 1998:
Pharmacological interventions for neuropsychiatric symptoms of HIV disease

De Luca, A.; Pierno, S.; Conte Camerino, D., 1994:
Pharmacological interventions for the changes of chloride channel conductance of aging rat skeletal muscle

Damaj, M.I.; Glassco, W.; Marks, M.J.; Slobe, B.; James, J.R.; May, E.L.; Rosecrans, J.A.; Collins, A.C.; Martin, B.R., 1997:
Pharmacological investigation of - and -cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo- isoquinoline, a bridged-nicotine analog

Truong, D.D.; Schwartz, P.H.; Lambert, T.L.; Wasterlain, C.G., 1992:
Pharmacological investigation of a novel rat model of posthypoxic myoclonus

Baudet, S.; Noireaud, J., 1997:
Pharmacological investigation of isometric contraction-relaxation coupling in rabbit isolated ventricular muscles

Ohkubo, H.; Ino, M.; Segawa, M.; Momo, K.; Tachiiri, T.; Imai, S., 1990:
Pharmacological investigation of kc 764 a new antiplatelet drug in experimental animals

Damaj, M.I.; Martin, B.R., 1996:
Pharmacological investigation of lobeline, a nicotinic receptor ligand

Dolzer, J.; Krannich, S.; Stengl, M., 2008:
Pharmacological investigation of protein kinase C- and cGMP-dependent ion channels in cultured olfactory receptor neurons of the hawkmoth Manduca sexta

Wahl, H.G.; Erley, C.M.; Braun, N.; Risler, T.; Liebich, H.M., 1998:
Pharmacological investigation of renal handling of 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in humans

Verma, S.P.; Garg, S.K.; Garg, B.D., 1992:
Pharmacological investigations into the effect of 5-hydroxytryptamine on oesophagus, crop and proventriculus of WLH chicken

Shankar,K.R.; ChandralekhaGurjar; Khatoon,B.A., 2008:
Pharmacological investigations of Crotalaria labumifolia

Georgiev, V.N., 1997:
Pharmacological investigations of the antimutagenic properties of ubiquinone-10

Grasse, K.L.; Ariel, M.; Smith, I.D., 1990:
Pharmacological isolation of visual cortical input to the accessory optic system of cat effects of intraocular injections of bicuculline methiodide on dtn responses

Weiner, M.F.; Schneider, L.S.; Gray, K.F.; Stern, R.G., 1996:
Pharmacological management and treatment of dementia and secondary symptoms

Hao, J.X.; Xu, X.J.; Aldskogius, H.; Seiger, A.; Wiesenfeld Hallin, Z., 1994:
Pharmacological management of a chronic pain-like response in spinally injured rats

Dodman, N.H.; Shuster, L.; Court, M.H.; Parker, D., 1989:
Pharmacological management of abnormal behavior

Gould, M.K.; Raffin, T.A., 1995:
Pharmacological management of acute and chronic bronchial asthma

Jain, P.; Vlay, S.C., 1992:
Pharmacological management of acute myocardial infarction

Van Gelder, I.C.; Brügemann, J.; Crijns, H.J., 1997:
Pharmacological management of arrhythmias in the elderly

Porter, R.W.; Ralston, S.H., 1994:
Pharmacological management of back pain syndromes

Schug, S.A.; Dunlop, R.; Zech, D., 1992:
Pharmacological management of cancer pain

Wilkie, D.J., 1993:
Pharmacological management of cancer pain: summary of the science

Cherry, D.A.; Gourlay, G.K., 1994:
Pharmacological management of chronic pain: a clinician's perspective

McNicholas, T.A.; Thomson, K.; Rogers, H.S.; Blandy, J.P., 1989:
Pharmacological management of erections during transurethral surgery

Schmitt, E.; D.L.S.ta R.L.; Savio, J.D.; Thatcher M J.; Thatcher, W.W., 1992:
Pharmacological management of follicular cysts ultrasonographic evaluation

Klinkenberg-Knol, E.C.; Festen, H.P.; Meuwissen, S.G., 1995:
Pharmacological management of gastro-oesophageal reflux disease

Miller, K., 1994:
Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents

Ungemach, F.R., 1991:
Pharmacological management of inflammation

Rose, C.D.; Doughty, R.A., 1992:
Pharmacological management of juvenile rheumatoid arthritis

Pfefferbaum, B.; Hagberg, C.A., 1993:
Pharmacological management of pain in children

Pritchett, Edward, L.C., 1994:
Pharmacological management of patients with atrial fibrillation

Burgess, J.A.; Johnson, B.D.; Sommers, E., 1990:
Pharmacological management of recurrent oral mucosal ulceration

Gregory, C.; McKenna, P., 1994:
Pharmacological management of schizophrenia in older patients

Jacob, S.W., 1996:
Pharmacological management of snoring

Hanlon, J.T.; O'brien J.G., 1989:
Pharmacological management of the elderly patient with terminal cancer pain

Roe, Christopher, J., 1993:
Pharmacological management of the elderly with renal disease

Neal, Durwood, E.Jr, 1993:
Pharmacological management of urinary retention in prostate cancer

Eckman, C.B.; Prada, C M.; Younkin, S.G., 1995:
Pharmacological manipulation of Alzheimers amyloid beta protein in vitro and in vivo

Martin, E.J.; Meyer, E.M., 1992:
Pharmacological manipulation of NGF/protein kinase C interactions in PC12 cells

Ptak, L.R.; L.E.S.; Lin, D.H.; Buhrfiend, C.M.; Carvey, P.M., 1991:
Pharmacological manipulation of a nucleus accumbens nacc derived trophic factor and its effect on mesencephalic culture growth

Bond, A.J., 1992:
Pharmacological manipulation of aggressiveness and impulsiveness in healthy volunteers

Ervin, F.R.; Palmour, R.M.; Dongier, M.H., 1994:
Pharmacological manipulation of alcohol consumption in vervet monkeys

Hirst, D.G.; Tozer, G.M., 1992:
Pharmacological manipulation of blood flow

Paul, C.; Bolton, C., 1994:
Pharmacological manipulation of blood-brain barrier breakdown during recovery from experimental allergic encephalomyelitis in the Lewis rat

Witte, E.A.; Marrocco, R.T., 1993:
Pharmacological manipulation of brain cholinergic activity modifies covert orienting in rhesus monkey

Kovelowski, C.J.II.S.hneider J.S., 1990:
Pharmacological manipulation of cognitive performance and impersistence in motor asymptomatic monkeys chronically exposed to mptp

Fredow, G.; Schmidt, D., 1989:
Pharmacological manipulation of different neurotransmitter systems in a mutant hamster model of paroxysmal dystonia

Zuddas, A.; Vaglini, F.; Fornai, F.; Corsini, G.U., 1990:
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum a new therapeutical approach to parkinsons disease

Monmaur, P.; Frankel-Kohn, L.; Sharif, A.; Gratio, V.; M'Harzi, M., 1998:
Pharmacological manipulation of hippocampal nitric oxide synthesis affects the power of theta recorded from the dorsal hippocampus of urethane-anesthetized rat

Ludvig, N.; Altura, B.T.; Altura, B.M.; Fox, S.E., 1995:
Pharmacological manipulation of hippocampal place cell firing with microdialysis in the recording site

Buffey, J.; Bleehen, S.S.; Macneil, S., 1989:
Pharmacological manipulation of intracellular calcium and protein kinase c alters melanogenesis in b16 melanoma cells

Diergaarde, L.; Schoffelmeer, A.N.M.; De Vries, T.J., 2008:
Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories

Bowman, W.C., 1997:
Pharmacological manipulation of neuromuscular transmission

Davidson, M.C.; Villarreal, M.A.; Marrocco, R.T., 1994:
Pharmacological manipulation of noradrenaline activity influences covert orienting in rhesus monkey

Kamradt, M.; Mohideen, N.; Krueger, E.; Sokolova, I.A.; Khodarev, N.N.; Vaughan, A.T.M., 1997:
Pharmacological manipulation of radiation induced apoptosis in a cervical carcinoma cell line

Asghar, S.S., 1996:
Pharmacological manipulation of the complement system in human diseases

Gough, D.B.; Ryan, P.C.; Lennon, G.M.; Gorey, T.F.; Fitzpatrick, J.M., 1990:
Pharmacological manipulation of the human ureter an in vitro experimental study

Pearson, B.J.; Freund, R.K.; Palmer, M.R., 1997:
Pharmacological manipulation of the the beta-adrenergic receptor alters the expression of rapid acute neuronal tolerance to ethanol in Purkinje neurons of LAS rats

Tani, T.; Sakurai, K.; Kimura, Y.; Ishikawa, T.; Hidaka, H., 1992:
Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells

Hennigan, T.W.; Carpenter, R.; Begent, R.; Allen Mersh, T.G., 1989:
Pharmacological manipulation of vascular permeability increases tumor antibody uptake

Whittle, B.J.R., 1990:
Pharmacological manipulation of vasoactive mediators in gastric damage and protection

Renner, K.; Hoffman, C.; Westin, T.; Johnson, P., 1998:
Pharmacological manipulations of GABA alter hypothalamic 5HT and lordosis in estrogen-primed rats

Meloni, R.; Ross, S.; Gale, K., 1990:
Pharmacological manipulations of dopamine utilization by solid transplants of fetal substantia nigra in the rat

Gherezghiher, T.; Kuhlman, L.; Koss, M.C., 1991:
Pharmacological mechanism of action of dipivalyl alpha methyl epinephrine dpme

Chandler, S.H.; Trueblood, P.R., 1995:
Pharmacological mechanisms controlling trigeminal motoneuronal excitability

Yamada, H.; Gotoh, Y.; Sahara, T.; Kanai, M.; Kinoshita, N.; Tsukada, Y.; Sugai, T.; Sugita, M., 1995:
Pharmacological mechanisms of action of N-3601

Nutt, D.J., 1990:
Pharmacological mechanisms of benzodiazepine withdrawal

Pasternak, G.W., 1993:
Pharmacological mechanisms of opioid analgesics

Hammond, Donna, L., 1993:
Pharmacological mechanisms of pain modulation An update on delta opioid receptors

Delini Stula, A., 1993:
Pharmacological mechanisms of the long-term effects of antidepressants Do they differ from acute effects?

Finkelstein, Joel, S., 1996:
Pharmacological mechanisms of therapeutics Parathyroid hormone

Jones, Glenville, 1996:
Pharmacological mechanisms of therapeutics Vitamin D and analogs

Schulz, R.; Guth, B.D.; Heusch, G., 1989:
Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia

Bilkey, D.K.; Heynen, A.J., 1990:
Pharmacological mechanisms underlying hippocampal rsa

Horchakova, N.O.; Polyakova, I.F.; Bilets'ka T.O.; Puzen'kina N.M.; Shcherbak, O.V.; Hrynevych, O.I., 1990:
Pharmacological methods of treating urolithiasis

Hetey, L., 1990:
Pharmacological model for antipsychotics using lsd on rats simulating neurochemical changes in schizophrenia

Neary, P.; Cobbe, S.M.; Smith, G.L., 1998:
Pharmacological modelling of sarcoplasmic reticulum dysfunction seen in heart failure

Avramis, Vassilios, I., 1995:
Pharmacological models for 2 drug combinations against childhood leukemias

Costall, B.; Domeney, A.M.; Kelly, M.E.; Naylor, R.J., 1991:
Pharmacological models in the development of antipsychotic drugs new strategies

Porsolt, R.D.; Lenegre, A.; Mcarthur, R.A., 1991:
Pharmacological models of depression

Studenik, C.; Zhou, Z.; January, C.T., 1996:
Pharmacological models of long QT syndromes Implications for drug therapy and ion channel defects

Berry, M.D.; Jordens, R.; Gillott, C.; Boulton, A.A., 1997:
Pharmacological modification of Drosophila melanogaster life-span

Kocsis, J.D.; Black, J.A.; Waxman, S.G., 1993:
Pharmacological modification of axon membrane molecules and cell transplantation as approaches to the restoration of conduction in demyelinated axons

Trevethick, M.A.; Strong, P.A., 1991:
Pharmacological modification of indomethacin induced gastric antral lesions in the re fed rat

Neijens, H.J.; Degenhart, H.J.; Van Der Maarel, H.; Kerstens, L.C.M., 1989:
Pharmacological modification of responses of purified neutrophilic and eosinophilic leukocytes obtained from asthmatic and healthy children

Thibaut, F.; Bonnet, J.J.; Vaugeois, J.M.; Costentin, J., 1996:
Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice

Angielski, Stefan, 1992:
Pharmacological modifications of hormonal and metabolic regulation of glomerular dynamics

Massey, S.C.; Mills, S.L., 1995:
Pharmacological modulation of AII gap junctions in the rabbit retina

Barbaccia, M.L.; Roscetti, G.; Trabucchi, M.; Purdy, R.H.; Mostallino, M.C.; Concas, A.; Biggio, G., 1996:
Pharmacological modulation of GABAergic transmission affects neurosteroid content in rat brain

Nakaya, Haruaki, 1997:
Pharmacological modulation of K+ channels in atrial cells

Pette, M.; Pette, D.F.; Muraro, P.A.; Martin, R.; Mcfarland, H.F., 1997:
Pharmacological modulation of T helper type 1 effector functions in vitro

Epstein, D.H.; Pohorecky, L.A., 1992:
Pharmacological modulation of acute-ethanol-induced memory blackouts in rats

Egido, J.; Ortiz, A.; Robles, A.; Gomez Chiarri, M.; Lerma, J.L.; Gomez, C.; Hernando, L.; Gonzalez, E., 1991:
Pharmacological modulation of adriamycin induced nephropathy in rats

Garssen, J.; Van Loveren, H.; Van Der Vliet, H.; Nijkamp, F.P., 1992:
Pharmacological modulation of airway hyperresponsiveness induced by early acting t cells in cellular immunity

Govoni, S.; Paolillo, M.; Racchi, M.; Zanassi, P.; Florio, T.; Thellung, S.; Schettini, G., 1998:
Pharmacological modulation of amyloid precursor protein processing in rat cortical astrocytes

Selig, W.M.; Tocker, J.E.; Welton, A.F., 1989:
Pharmacological modulation of antigen induced pulmonary pathophysiologic responses in the isolated guinea pig lung

Post, M.J.; T.B.esebeek J.D.; Wemer, J.; Van Rooij, H.H.; Porsius, A.J., 1990:
Pharmacological modulation of arachidonic acid metabolism in the isolated rat lung by selective phosphodiesterase inhibitors

Tang, Q.; Bashor, D.P.; Roye, D.B., 1990:
Pharmacological modulation of atennular movements in blue crab

Panerai, A.E.; Sacerdote, P., 1989:
Pharmacological modulation of beta endorphin in lymphocytes

Siergiejko, Z.; Chyrek Borowska, S., 1995:
Pharmacological modulation of bronchial hyperreactivity in asthma patients

Zhang, D.; Blute, T.A.; Eldred, W.D., 1994:
Pharmacological modulation of cGMP levels in specific cell types in the turtle retina

Klöckner, U.; Trieschmann, U.; Isenberg, G., 1989:
Pharmacological modulation of calcium and potassium channels in isolated vascular smooth muscle cells

Nakaya, H.; Mori, K.; Hara, Y., 1996:
Pharmacological modulation of cardiac Na+-activated K+ channels

Smits, J.F.M.; Daemen, M.J.A.P.; Cleutjens, J.P.M.; Van Krimpen, C.; Schoemaker, R.G., 1991:
Pharmacological modulation of cardiac remodeling in pathophysiological conditions

Matsuoka, S.; Hilgemann, D.W., 1993:
Pharmacological modulation of cardiac sodium-calcium exchange current in whole-cell voltage clamped guinea pig and and rabbit myocytes

Fischer, W., 1991:
Pharmacological modulation of central noradrenergic mechanisms and influence of selected drugs on chemical induced seizures strychnine seizure pattern test mouse

Calder, A.A.; Greer, I.A., 1991:
Pharmacological modulation of cervical compliance in the first and second trimesters of pregnancy

Bowen, W.P.; Mcmurray, H.F.; Lall, S.; Baxter, G.S.; Coleman, R.A., 1998:
Pharmacological modulation of chloride ion efflux from T84 cells

Vilarino, N.; Vieytes, M.R.; Botana, L.M., 1997:
Pharmacological modulation of compound 48/80-induced calcium changes in rat mast cells

Schmidt, J.; Fleissner, S.; Heimann Weitschat, I.; Lindstaedt, R.; Szelenyi, I., 1995:
Pharmacological modulation of cytokine production of murine T-H2-type T cells in vitro

Ghezzi, P.; Mengozzi, M.; Bertini, R.; Mantovani, A., 1990:
Pharmacological modulation of cytokines

Manuel, N.A.; Davies, C.H., 1997:
Pharmacological modulation of depolarizing GABAA receptor-mediated IPSPs in rat hippocampal CA1 pyramidal neurones

Mills, J.D.; David, J.A.; Pitman, R.M., 1995:
Pharmacological modulation of electrical events recorded from a cockroach motoneurone in vitro

Wautier, J.L.; Wautier, M.P.; Guillausseau, P.J., 1989:
Pharmacological modulation of erythrocyte adhesion to endothelium in diabetes mellitus

Fareed, J.; Bacher, P.; Messmore, H.L.; Walenga, J.M.; Hoppensteadt, D.A.; Strano, A.; Pifarre, R., 1992:
Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs

Fareed, J.; Walenga, J.M.; Pifarre, R.; Hoppensteadt, D., 1990 :
Pharmacological modulation of fibrinolysis in experimental animals and man

Allescher, H.D., 1991:
Pharmacological modulation of gastrointestinal motility and secretion

Marone, G.; Spadaro, G.; Genovese, A., 1995:
Pharmacological modulation of human mast cell and basophil secretion in vitro and in vivo

Damji, K.F.; Rootman, J.; Palcic, B.; Thurston, G., 1990:
Pharmacological modulation of human subconjunctival fibroblast behavior in vitro

Puspok, A.; Steindl, P.; Ebner, J.; Ferenci, P., 1991:
Pharmacological modulation of hyperammonemic encephalopathy in rats

Pelikan, Z.; Pelikan Filipek, M., 1991:
Pharmacological modulation of immediate iar and late lar asthmatic response to allergen challenge

Dam, T.N.; Kang, S.; Nickoloff, B.J., 1997:
Pharmacological modulation of induction and treatment of psoriasis using human skin grafts transplanted onto SCID mice

Bender, P.E.; Lee, J.C., 1990:
Pharmacological modulation of interleukin 1

Roberge, C.J.; Grassi, J.; Poubelle, P.E., 1991:
Pharmacological modulation of interleukin 1 production by normal human blood neutrophils

Christen, M.O., 1990:
Pharmacological modulation of irritable bowel syndrome ibs

Johshita, H.; Asano, T., 1993 :
Pharmacological modulation of ischemic brain edema Effects of various putative anti-edema agents focal cerebral ischemia in cats

Lee, T.H., 1989:
Pharmacological modulation of leukotriene and platelet activating factor biosynthesis and activities by alternative dietary fatty acids

Mackiewicz, U.; Konys, J.; Wiktorowicz, K.; Pawlik, I., 1994:
Pharmacological modulation of lymphocyte function in atopic allergy II The effect of adenosine on lymphocyte proliferative response

Vetulani, Jerzy, 1995:
Pharmacological modulation of memory - Introductory remarks

Juric, D.M.; Stangelj, M.L.pnik; Carman Krzan, M., 1997:
Pharmacological modulation of nerve growth factor secretion from astrocytes by cytokines and neurotransmitters

Sánchez Crespo, M.; Fernández-Gallardo, S., 1991:
Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock

Gelband, C.H.; Hume, J.R., 1992:
Pharmacological modulation of potassium channels in isolated canine renal artery cells

Danzebrink, R.M.; Gebhart, G.F., 1990:
Pharmacological modulation of pressor and visceromotor responses to colorectal distension crd in the rat

Vaglini, F.; Zuddas, A.; Fornai, F.; Corsini, G.U., 1990:
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion a new therapeutical approach to parkinsons disease

Recio, M.C.; Huguet, A.I.; Manez, S.; Giner, R.M.; Rios, J.L., 1997:
Pharmacological modulation of resiniferatoxin-induced ear edema

McDonough, J.H.; Shih, T.M., 1993:
Pharmacological modulation of soman-induced seizures

Ogawa, H.; Shimizu, R.; Tsuji, N.; Suzuki, K.; Oka, K.; Tanishita, K., 1998:
Pharmacological modulation of spike latency in the earthworm giant fiber in response to tactile stimulus

Tsubokawa, H.; Ross, W.N., 1996:
Pharmacological modulation of spike propagation in the apical dendrites of hippocampal pyramidal cells

Tranquille, N.; Emeis, J.J., 1990:
Pharmacological modulation of the acute release of tissue type plasminogen activator from endothelial cells

Brownlee, M., 1989:
Pharmacological modulation of the advanced glycosylation reaction

Lagente, V.; Chabrier, P.E.; Mencia Huerta, J.M.; Braquet, P., 1989:
Pharmacological modulation of the bronchopulmonary response to endothelin administered by aerosol in the guinea pig

Reyners, A.K.L.; Vlutters, F.G.; Tio, R.; Smit, A.J.; Reitsma, W.D., 1996:
Pharmacological modulation of the cold face test by digoxin and enalapril

Mangiafico, S.; Bonini, S.; Schivaone, M.; Berruto, A.; Centofanti, M.; Cantera, E.; Rizzo, P., 1990:
Pharmacological modulation of the early and late phase ocular reaction in human hay fever

Dugas, B.; Lagente, V.; Mencia-Huerta, J.M.; Braquet, P., 1991:
Pharmacological modulation of the expression of the low affinity IgE receptor

Paul Eugene, N.; Dugas, B.; Lagente, V.; Mencia Herta, J.M.; Braquet, P., 1990 :
Pharmacological modulation of the fc epsilon rii cd23 expression on human monocytes and the human monocytic cell line u 937

Casadevall, M.; Panes, J.; Salas, A.; Molla, M.; Osorio, J.L.; Conill, C.; Granger, D.N.; Pique, J.M., 1998:
Pharmacological modulation of the inflammatory response induced by abdominal irradiation

Mattiasson, A., 1995:
Pharmacological modulation of the micturition reflex at the spinal cord level and peripherally

Brugger, F.; Pozza, M.F.; Wicki, U.; Nassenstein, D.; Olpe H R.; Fagg, G.E., 1990:
Pharmacological modulation of the nmda receptor by agonists and antagonists at the strychnine insensitive glycine site

Friedmann, P.S., 1990:
Pharmacological modulation of the skin immune system

Himmel, H.M.; Amos, G.J.; Wettwer, E.; Metzger, F.; Ravens, U., 1995:
Pharmacological modulation of the transient outward current in human ventricular myocytes

Lee, K.; Rowe, I.C.M.; Ashford, M.L.J., 1994:
Pharmacological modulation of the trypsin modified K-ATP in the CRI-G1 insulin-secreting cell line

May, G.R.; Love Jones, S.J.; Page, C.P., 1990:
Pharmacological modulation of thrombin induced cerebral embolism

Harenberg, J., 1995:
Pharmacological modulation of tissue factor pathway inhibitor

Alcalay, M.; Izraeli, S.; Wallach-Kapon, R.; Tochner, Z.; Benjamini, Y.; Akselrod, S., 1991:
Pharmacological modulation of vagal cardiac control measured by heart rate power spectrum: a possible bioequivalent probe

Urenjak, J.; Obrenovitch, T.P., 1996:
Pharmacological modulation of voltage-gated Na+ channels: a rational and effective strategy against ischemic brain damage

Siegal, T.; Ovadia, H.; Abramsky, O., 1997:
Pharmacological modulations of delayed radiation induced injury to the spinal cord Possible shared cause for increased vascular permeability and enhanced production of endothelin

Serre Debeauvais, F.; Zaoui, P.; Egelhoffer, H.; Bayle, F.; Jeanneau Nicolle, E.; Maurizi, J.; Janbon, B.; Bessard, G., 1992:
Pharmacological monitoring of azathioprine therapy

Vertkin, A.L.; Masharova, A.A.; Bezborodny, S.D.; Gorodetsky, V.V.; Khimitch, Y.A.; Vovk, E.I.; Artamonov, V.P., 1997:
Pharmacological monitoring of ranitidine in treating patients with chronical alcohol intoxication for gastro-duodenal ulcers

Nakata, Y.; Jino, H.; Nakamura, S.; Shirahase, H.; Usui, H.; Kurahashi, K., 1996:
Pharmacological natures of arachidonic acid -induced endothelium-dependent contraction in rat intra-pulmonary artery

Michalek-Sauberer, A.; Gradwohl-Matis, I.; Dumitrescu, R.V.; Gruber, A.; Spiss, C.K.; Illievich, U.M., 1996:
Pharmacological neuronal protection

White, T.E.; Schrimsher, G.W.; Anderson, D.K.; Theele, D.P.; Reier, P.J., 1995:
Pharmacological neuroprotection and early viability of intraspinal fetal grafts

Shale, H.; Tanner, C., 1996:
Pharmacological options for the management of dyskinesias

Lennon, G.M.; Burke, J.G.; Ryan, P.C.; Fitzpatrick, J.M., 1992:
Pharmacological options for the treatment of ureteric colic an in vitro experimental study

Kenny, B.; Ballard, S.; Blagg, J.; Fox, D., 1997:
Pharmacological options in the treatment of benign prostatic hyperplasia

Sternieri, E.; Guaraldi, G.P.; Mazzi, F.; Venuta, M.; Orlandi, E.; Trenti, T.; Bertolotti, M.; Ferrari, A.; Pini, L.A., 1991:
Pharmacological outline of chronic headache patients Overlap between depressive and nociceptive symptomatology

Saxena, P.R.; Ferrari, M.D.; D.V.ies, P.; Villalon, C.M., 1997:
Pharmacological overview of new 5-HT-1D receptor agonists in development for the acute treatment of migraine

Marzio, L.; Pieramico, O.; Dimitri, A.; Grossi, L.; Cuccurullo, F., 1989:
Pharmacological pacing of phase iii of migrating myoelectrical complex mmcs in humans

Niemczyk, S.; Elwertowski, M.; Sitkowska Kurzec, Z.; Radomski, R.; Sokalski, A., 1996:
Pharmacological parathyroidectomy with local ethanol injections in chronic hemodialysed patients

Drozdova, E.I.; Pivovarov, A.S., 1993:
Pharmacological peculiarities of nicotinic and muscarinic receptors in Helix lucorum neurons

Pucilowski, Olgierd, 1994:
Pharmacological perspective on calcium channel blockers for alcohol and drug addiction

Cameron, J.M., 1994:
Pharmacological physiology of swimming

Branellec, D.; Chouaib, S., 1992:
Pharmacological potentiation of tnf mediated cell lysis in vitro

Ravingerova, T.; Ziegelhoeffer, A.; Koidl, B., 1998 :
Pharmacological preconditioning in isolated guinea pig cardiomyocytes the role of alpha-adrenergic stimulation

Ladilov, Yury; Maxeiner, Hagen; Balser, Claudia; Piper, Hans, M., 1998:
Pharmacological preconditioning in isolated rat cardiomyocytes

Welte, K.; Platzer, E.; Gabrilove, J.L.; Mertelsm, R.; Moore, M.A.S., 1997:
Pharmacological preparation comprising human pluripotent hematopoietic colony stimulating factor

Andersson, C M.A.; Bergstrand, H.S.A.; Hallberg, A.R.; Sarmstrand, B.O.; Sigvard, A.P., 1998:
Pharmacological preparations comprising a cystine derivative

Guslandi, M., 1990:
Pharmacological prevention and treatment of nsaid induced gastroduodenal lesions

Paoletti, Rodolfo, 1998:
Pharmacological prevention of atherosclerosis and cardiovascular disease

Bergqvist, D., 1992:
Pharmacological prevention of graft occlusion a review

Sobey, C.G.; Dalipram, R.A.; Woodman, O.L., 1992:
Pharmacological prevention of impaired coronary vasodilatation after ischaemia and reperfusion in dogs

Hara, H.; Kato, H.; Sukamoto, T.; Tsukamoto, G.; Kogure, K., 1994:
Pharmacological prevention of ischemia-induced brain damage

Patrono, C., 1991:
Pharmacological prevention of myocardial infarction and stroke

Ruedy, J., 1989 :
Pharmacological principles applied to antiviral treatment in aids

Dudley, M.N., 1995:
Pharmacological principles of antiretroviral therapy with nucleosides

Conrad, K.A.; Ewy, G.A., 1992:
Pharmacological principles of cardiovascular drug therapy

Kleking, G.P.; Bokarev, I.N., 1990:
Pharmacological principles of thrombolytic therapy

Stein, C.M.; Kinirons, M.T.; Pincus, T.; Wilkinson, G.R.; Wood, A.J.J., 1995:
Pharmacological probes of cytochrome P4503A activity and cyclosporin concentrations

Roberts, J.; Snyder, D.; Aloyo, V.; Johnson, M., 1993:
Pharmacological probes to assess the effect of age on NE-release from cardiac synaptosomes in male F344 rats

Durnev, A.D.; Seredenin, S.B., 1993:
Pharmacological problems in the search and use of antimutagens

Rotten, D., 1995:
Pharmacological procedures for inducing labour

Stutzmann, J.M.; Mignani, S.; Debarnot, F.; Rataud, J.; Piot, O.; Pauchet, C.; Jimonet, P.; Reibaud, M.; Malgouris, C.; Uzan, A.; Pratt, J.; Blanchard, J.C.; Barreau, M., 1993:
Pharmacological profile and neuroprotective activities of RP 66055, a riluzole derivative, in rodents

Nakayama, Koichi, 1996:
Pharmacological profile and therapeutic perspectives of semotiadil fumarate , a novel benzothiazine Ca-2+ antagonist

Awane, Yumiko; Kusumoto, Keiji; Kubo, Kazuki; Kawata, Akira; Kikuchi, Takashi; Wakimasu, Mitsuhiro; Watanabe, Toshifumi; Fujino, Masahiko, 1994:
Pharmacological profile in vitro of a new endothelin receptor antagonist, TAK-044

Nishida, A.; Miyata, K.; Tsutsumi, R.; Yuki, H.; Akuzawa, S.; Kobayashi, A.; Kamato, T.; Ito, H.; Yamano, M., 1994:
Pharmacological profile of -1- -2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl-3-

Hamasuna, K.; Mochizuki, D.; Hokonohara, T.; Takayanagi, N., 1998:
Pharmacological profile of ACN111, a novel antipsychotic drug Comparative study of ACN111 and NMDA on dystonia in rats

Koga, K.; Mochizuki, D.; Takayanagi, N., 1998:
Pharmacological profile of ACN111, a novel antipsychotic drug Effects on PCP-induced disruption of prepulse inhibition of acoustic startle response

Hokonohara, T.; Mochizuki, D.; Takayanagi, N., 1998:
Pharmacological profile of ACN111, a novel antipsychotic drug Relation with the function of NMDA receptor in the medial prefrontal cortex

Chen, S.; Inoue, R., 1993:
Pharmacological profile of ACh-evoked cationic currents in guinea pig ileal smooth muscle

Someya, Y.; Tahara, A.; Nakano, R.; Matsuyama-Yokono, A.; Nagase, I.; Fukunaga, Y.; Takasu, T.; Hayakawa, M.; Shibasaki, M., 2008:
Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo

Kawasaki, K.; Yamada, S.; Tsujita, R.; Kasahara, K.; Kitamura, Y.; Hokonohara, T.; Mochizuki, D.; Hashimoto, S.; Kogami, Y.; Sagai, H.; Yamamoto, S., 1997:
Pharmacological profile of AZ-16596, a novel 5-HT1A receptor full agonist Biochemical and electrophysiological characterization

Kitamura, Y.; Mochizuki, D.; Hashimoto, S.; Ikuhara, T.; Kogami, Y.; Sagai, H.; Yamamoto, S., 1997 :
Pharmacological profile of AZ-16596, a novel 5-HT1A receptor full agonist Pharmacological characterization

Koga, K.; Mochizuki, D.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Behavioral studies

Tsujita, R.; Yamada, S.; Mochizuki, D.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Biochemical analysis

Mochizuki, D.; Hokonohara, T.; Hamasuna, K.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Effects on motor functions

Hokonohara, T.; Mochizuki, D.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Electrophysiological analysis

Yamada, S.; Mochizuki, D.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Microdialytic analysis

Nakazono, O.; Mochizuki, D.; Yamamoto, S., 1997:
Pharmacological profile of AZ-21666, a novel antipsychotic drug Transcription studies

Neumann, J.; Scholz, H.; Zimmermann, N., 1997:
Pharmacological profile of CGP 48506, a new positive inotropic agent

Schlegelmilch, R.; Straumann, D.; Statkow, P.; Chatterjee, S.S., 1994:
Pharmacological profile of CRE 652, a new organic mononitrate

Gillberg, P.G.ran; Sundquist, S., 1997:
Pharmacological profile of DD01 and desethyloxy-butynin the major metabolite of tolterodine and oxybutynin , respectively

Guitart, X.; Ballarin, M.; Carceller, A.; Codony, X.; Dordal, A.; Hernandez, E.; Laloya, M.; Perez, R.; Ruiz, M.T.; Farre, A.J., 1997:
Pharmacological profile of E-5842, a sigma receptor ligand with atypical antipsychotic activity in animal models

Ueno, M.; Hatakeyama, S.; Kubota, A.; Shinoda, Y.; Yamanishi, Y.; Nishizawa, Y., 1997:
Pharmacological profile of E2040 A new antipsychotic with D3/D2/5-HT2 antagonist activities

Nagura, J.; Yasuda, S.; Ito, Y.; Yamamoto, M.; Kawano, K.; Hachisu, M.; Konno, F., 1995:
Pharmacological profile of EF2831, a metabolite of AT-1 receptor antagonist ME3221

Bartoszyk, G.D.; Greiner, H.E.; Seyfried, C.A., 1997:
Pharmacological profile of EMD 128130 A putative atypical antipsychotic with dopamine D2 antagonistic and serotonin 5-HT1A agonistic properties

Carr, R.D.; Fraser Rae, L.; Killingback, P.G.; Hallam, C.; Harper, S.T., 1992:
Pharmacological profile of FPL 66564 The first ultra short-acting angiotensin-converting enzyme inhibitor in the rat

Uchida, H.; Inagawa, K.; Tameda, C.; Miyauchi, T., 1995:
Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist

Miyauchi, T.; Inagawa, K.; Uchida, H.; Tameda, C.; Sakakibara, M., 1993:
Pharmacological profile of HT-90B, a putative anxiolytic with potent antidepressive activity

Cowan, A.; Vasthare, U.S.; Tuma, R.F.; Hong, Y.; Carlsson, C., 1995:
Pharmacological profile of ICI 204448, a peripherally acting, kappa-selective opioid agonist

Fukamizu, Yuji; Itoh, Nobuko; Hata, Yoshiyuki; Nakajima, Tsutomu; Kimura, Kunio; Fujii, Masahiro, 1997:
Pharmacological profile of KP- 105, a novel histamine H-2- receptor antagonist

Eguchi, J.I.hi; Yuasa, T.Y.ki; Egawa, M.; Tobe, A., 1994:
Pharmacological profile of MCI-225 on the central nervous system Its antidepressant activity

IIzuka, H.; Kojima, S.; Fukuzaki, A.; Osaka, Y.; Tsuchiya, S., 1996:
Pharmacological profile of MM-218, a novel 5-HT-3 receptor antagonist

Ferkany, J.W.; Hamilton, G.S.; Patch, R.J.; Huang, Z.; Borosky, S.A.; Bednar, D.L.; Jones, B.E.; Zubrowski, R.; Willetts, J.; Karbon, E.W., 1993:
Pharmacological profile of NPC 17742 -7-phosphonoheptanoic acid, a potent, selective and competitive N-methyl-D-aspartate receptor antagonist

Tottori, K.; Kikuchi, T.; Uwahodo, Y.; Nakai, M.; Miwa, T.; Oshiro, Y.; Morita, S., 1996:
Pharmacological profile of OPC-14523 A novel sigma and 5-HT1A receptor agonist

Nakai, M.; Tottori, K.; Kikuchi, T.; Uwahodo, Y.; Miwa, T.; Oshiro, Y.; Morita, S., 1996:
Pharmacological profile of OPC-14523 Effects on learning and memory impairment

Kikuchi, T.; Tottori, K.; Uwahodo, Y.; Miwa, T.; Hirose, T.; Fujiwara, K.; Oshiro, T.; Morita, S., 1995:
Pharmacological profile of OPC-14597, a novel antipsychotic drug Presynaptic dopamine autoreceptor agonistic activity and postsynaptic dopamine D-2 receptor antagonistic activity

Uwahodo, Y.; Kikuchi, T.; Tottori, K.; Miwa, T.; Hirose, T.; Fujiwara, K.; Oshiro, Y.; Morita, S., 1995:
Pharmacological profile of OPC-14597, a novel antipsychotic drug Weak extrapyramidal side effects

Krutz, E.S.; Bailey, S.C.; Hellyer, L.D.; Dominquez, A.A.; Prazekop, P.A.; Ortega Nanos, M.C.; Freed, B.S.; Hamer, R.R.L.; Tegler, J.J., 1993:
Pharmacological profile of P-9782 A protein kinase C inhibitor with topical antiinflammatory and antiproliferative activity

Matsuda, Yuzuru; Tanaka, Takeo; Morishita, Yoshikazu; Nozawa, Mika; Ohno, Tetsuji; Yamada, Koji, 1993:
Pharmacological profile of RES-701-1, a novel, potent endothelin subtype B receptor antagonist of microbial origin

Ohno, Y.; Ishida, K.; Ishibashi, T.; Nakamura, M., 1994:
Pharmacological profile of SM-13496, a novel antipsychotic agent with minimal extrapyramidal and CNS depressive side effects

Serradeil, L.Gal, C., 1994:
Pharmacological profile of SR 49059, a new potent and specific vasopressin V-1a receptor antagonist

Hoshino, T.; Yamauchi, R.; Ban, Y.; Kirkkawa, K.; Murata, S., 1996:
Pharmacological profile of T-0115, a potent nonpeptide endothelin receptor antagonist

Yamauchi, R.; Hoshino, T.; Ban, Y.; Aihara, H.; Kikkawa, K.; Yabana, H.; Murata, S., 1997:
Pharmacological profile of T-0201, a potent nonpeptide endothelin antagonist, and preferable effects in models of pulmonary hypertension induced by monocrotaline

Taniguchi, H.; Yazaki, N.; Yomota, E.; Shikano, T.; Endo, T.; Nagasaki, M., 1996:
Pharmacological profile of T-0632, a novel CCK-A receptor antagonist, in vivo

Nagasaki, M.; Taniguchi, H.; Yazaki, N.; Endo, T., 1996:
Pharmacological profile of T-0632, a novel CCK-A receptor antagonists, in vitro

Hihashide, Y.; Yatabe, Y.; Nakajima, Y.; Yamaura, T., 1996:
Pharmacological profile of TAC-363, novel tachykinin NK-2 receptor antagonist

Manome, Y.; Sasamori, J.; Murata, T.; Aihara, K.; Kogi, K., 1997:
Pharmacological profile of TY-12283, a novel 5-HT-2A receptor antagonist

Gordon, R.; Bernard, P.; Paek, E.; Lee, K.; Choi, Y.M., 1998 :
Pharmacological profile of YKP 10A A novel antidepressant

Nishida, A.; Akuzawa, S.; Kobayashi, A.; Yuki, H.; Satoh, M.; Miyata, K.; Honda, K., 1993:
Pharmacological profile of YM022, a potent and selective gastrin-cholecystokinin B receptor antagonist

Tanaka, T.; Fukuta, Y.; Fukuda, Y.; Higashino, R.; Ito, S.; Sato, R.; Takei, M.; Kurimoto, T.; Tamaki, H., 1997:
Pharmacological profile of Z-335, a novel thromboxane A-2/prostaglandin H-2 receptor antagonist

Wilson, C.; Heys, C.; Hunt, S.J.; Kelly, E.; Mortlock, A.; Tang, E.; Wright, N., 1997:
Pharmacological profile of Z-ETA-1, a novel orally active endothelin ET-A receptor antagonist

Fink Jensen, A.; Nielsen, E.B.; Hohlweg, R.; Naerum, I.; Crider, M.; Ghosh, D.; Cruse, S.; Scheideler, M.A., 1995:
Pharmacological profile of a benzindole with high affinity and selectivity for the dopamine D3 receptor

Shibouta, Yumiko; Inada, Yoshiyuki; Ojima, Mami; Wada, Takeo; Noda, Masakuni; Sanada, Tsukasa; Kubo, Keiji; Kohara, Yasuhisa; Naka, Takehiko; Nishikawa, Kohei, 1993:
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1 biphenyl-4-yl-1H-benzimidazole-7-carboyxlic acid

Nakashima, M.; Kobayashi, S.; Yonetani, Y., 1992:
Pharmacological profile of a new diuretic agent s 8666 in healthy volunteers

Igata, Yumiko; Kusumoto, Keiji; Ikeda, Shota; Fujwara, Shuji; Igata, Hideki; Kitayoshi, Takahito; Maekawa, Tsuyoshi; Shiraishi, Mitsuru; Watanabe, Toshifumi, 1996:
Pharmacological profile of a new potassium channel opener, TAK-636; vasorelaxant effects and anti anginal effects

Yamamoto, M.; Akiyama, T.; Tachibana, I.; Senga, Y.; Otsuki, M., 1997:
Pharmacological profile of a new serine derivative cholecystokinin-A receptor antagonist TP-680

Hesse, G.W.; Shashoua, V.E., 1991:
Pharmacological profile of a novel dopamine fatty acid bioconjugate with cns activity

Yoshida, N.; Omoya, H.; Oka, M.; Furukawa, K.; Ito, T.; Karasawa, T., 1989:
Pharmacological profile of a novel gastrokinetic agent as 4370

Kumar, K.N.; Eggeman, K.T.; Johnson, P.S.; Babcock, K.; Michaelis, E.K., 1991:
Pharmacological profile of a partially purified n methyl d aspartate receptor complex and hydrodynamic characterization of the agonist binding subunit

Conn, P.J.; Boss, V., 1993:
Pharmacological profile of a phospholipase D-coupled metabotropic excitatory amino acid receptor

Wood, J.; Buchdunger, E.; Cozens, R.; Hofmann, F.; Mestan, J.; Mett, H.; Mueller, M.; Roesel, J.; Schnell, C.; Stover, D.; Woods Cook, K.; Bold, G.; Frei, J.; Towbin, H.; Kotyuk, B.; Sills, M.; Wass, K.; Martiny Baron, G.; Siemeist, 1998:
Pharmacological profile of a potent and orally active inhibitor of VEGF receptor tyrosine kinases

Grau, M.; Montero, J.L.; Felipe, A.; Carrasco, E.; Guasch, J., 1989:
Pharmacological profile of aceclofenac a new nonsteroid antiinflammatory

Blue, D.R.; Whiting, R.L.; Clarke, D.E., 1991:
Pharmacological profile of an alpha 1a adrenoceptor in the renal vasculature studies with dextro and levo niguldipine

Prino, G., 1989:
Pharmacological profile of ateroid

Takita, M.; Mikuni, M.; Takahashi, K., 1990:
Pharmacological profile of brain glucose utilization studied by the on line brain microdialysis

Franzius, D.; Hoth, M.; Penner, R., 1994:
Pharmacological profile of calcium entry in mast cells

Green, J.R.; Jaeggi, K.A.; Mueller, K., 1991:
Pharmacological profile of cgp 42446 a new highly potent anti osteolytic bisphosphonate

Bennett, D.A.; Sills, M.A.; Williams, M.; Gerber, R.; Amrick, C.L.; Boyar, W.C.; Liebman, J.M.; Lovell, R.A.; Hutchison, A.J., 1989:
Pharmacological profile of cgs 18102a a proposed anxiolytic with 5ht 1a agonist and 5ht 2 antagonist properties

Louiset, E.; Cazin, L.; Duval, O.; Tonon, M.C.; Vaudry, H., 1990:
Pharmacological profile of cholinergic receptors in frog pituitary melanotrophs

Guerrini, R.; Capasso, A.; Sorrentino, L.; Manna, T.; Anacardio, R.; Bryant, S.D.; Lazarus, L.H.; Attila, M.; Salvadori, S., 1996:
Pharmacological profile of deltorphin B a new mu/delta opioid receptor agonist

Toska, K.; Scheideler, M.A., 1994:
Pharmacological profile of dopamine-D1A and -D5 receptor-mediated signal transduction

Lembeck, F.; Decrinis, M.; Pertl, C., 1989:
Pharmacological profile of endothelin

Huang, L.; Abuhamdah, S.; Howes, M-Jayne.R.; Dixon, C.L.; Elliot, M.S.J.; Ballard, C.; Holmes, C.; Burns, A.; Perry, E.K.; Francis, P.T.; Lees, G.; Chazot, P.L., 2008:
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels

Ebert, B.; Wafford, K.A.; Whiting, P.; Krogsgaard Larsen, P.; Kemp, J.A., 1993:
Pharmacological profile of four GABA-A agonists on recombinant GABA-A receptors expressed in Xenopus oocytes

Quinland, E.M.; Murphy, A.D., 1992:
Pharmacological profile of glutamatergic influence in the buccal CPG Helisoma trivolvis

Guo J Z.; Yoshioka, K.; Yanagisawa, M.; Hagan, R.M.; Otsuka, M., 1992:
Pharmacological profile of gr71251 a new tachykinin receptor antagonist in the isolated spinal cord of the newborn rat

Hoyer, D.; Kleuser, B.; Sutcliffe, J.G., 1997:
Pharmacological profile of human 5-hydroxytryptamine 5-HT-7 receptors expressed in insect cells using the baculovirus system

Cowan, A.; Daniel, J.L.; Ryan, R.R.; Wheeler Aceto, H., 1990:
Pharmacological profile of ici 21640 a novel bombesin antagonist

Guard, S.; Watling, K.J., 1992:
Pharmacological profile of iodine-125 bombesin binding to gastrin releasing peptide- and neuromedin B-preferring bombesin receptors in rat CNS

Berettera, C.; Belfiore, P.; Magnani, M.; Pozzi, O.; Pinza, M.; Dorigotti, L., 1990:
Pharmacological profile of isf 4185 a new potent nootropic

Ogawa, N.; Kaneta, S.; Jinno, Y.; Harada, K.; Ohta, H.; Fukushima, H.; Nishikori, K., 1990:
Pharmacological profile of krn 2391 a novel vasodilator

Fareed, J.; Welanga, J.M.; Hoppensteadt, D.; Ahsan, A.; Murphy, R.; Weber, S.; Pifarre, R., 1992:
Pharmacological profile of low molecular weight heparins Implications in prophylaxis and the treatment of thrombotic disorders

Baugh, L.; Abraham, W.; Matthews, E.; Lahr, P., 1989:
Pharmacological profile of MDL 26,024GO: a novel antiasthmatic agent

Kamerling, S.; Keowen, M.; Bagwell, C.; Jochle, W., 1991:
Pharmacological profile of medetomidine in the equine

Hayakawa, T.; Hagihara, K.; Arai, T.; Mino, S.; Tadokoro, T.; Tanaka, Y., 1992:
Pharmacological profile of n 3389 a novel 5 ht3 receptor antagonist

Fisas, M.A.; Gutierrez, B.; Corbera, J.; Vano, D.; Hernandez, E.; Perez, R.; Garcia, C.; Guitart, X., 1997:
Pharmacological profile of new series of calcium-antagonists as neuroprotectants

Hamon, G.; Fortin, M.; L.M.rtret, O.; Jouquey, S.; Vincent, J.C.aude; Bichet, D.G., 1994:
Pharmacological profile of niravoline a new aquaretic compound

Rivera, T.; Baughman, R.A.; Leipold, H.; Rosado, C.; Kutzy, T.; Mayer, E.; Leone Bay, A., 1996:
Pharmacological profile of oral heparin using derivatized non-alpha-amino acids

Smith Kurtz, E.L.; Elliott, M.E.; Hellyer, L.; Tegeler, J.; Hamer, R.R.L.; Martin, L.L., 1991:
Pharmacological profile of p 8977 a dual cyclooxygenase lipoxygenase inhibitor and topical antiinflammatory agent

Danks, P.; L.B.urdelles, B.; Myers, J.; Whiting, P.; Kemp, J.A.; Priestley, T., 1994:
Pharmacological profile of recombinant human NR1a+NR2A and native rat cerebellar granule cell NMDA receptors

O'donnell M.; Crowley, H.; Yaremko, B.; Welton, A., 1989:
Pharmacological profile of ro 24 0238 a novel compound with dual actions paf receptor antagonism and thromboxane a 2 synthase inhibition

Galliani, G.; Nencioni, A.; Formento, M.L.; Barzaghi, F., 1990:
Pharmacological profile of ru 35963 a new muscarinic agonist

Cordon, J.J.; Nikam, S.S.; Kornberg, B.E.; Campbell, G.W.; Vartanian, M.G.; Boxer, P.A., 1998:
Pharmacological profile of second generation PNQX analogs

Hay, D.W.P.; Luttmann, M.A.; Muccitelli, R.M.; Novak, L.B.; Osborn, R.R.; Underwood, D.C.; Foley, J.J.; Schmidt, D.B.; Sarau, H.M.; E.A., 1992:
Pharmacological profile of skf 107310 a novel peptidoleukotriene lt receptor antagonist

Zivkovic, B.; George, P.; Perrault, G.; Morel, E.; Joly, D.; Lourdelet, J.; Sanger, D.J., 1990:
Pharmacological profile of sl 85 0274 a novel imidazopyridine anxiolytic

Shimizu, H.; Hirose, A.; Kato, T.; Ohno, Y.; Tanaka, H.; Maruoka, Y.; Tatsuno, T.; Nakamura, M., 1990:
Pharmacological profile of sm 9018 a novel neuroleptic candidate

Siehler, S.; Nunn, C.; Hannon, J.; Feuerbach, D.; Hoyer, D., 2008:
Pharmacological profile of somatostatin and cortistatin receptors

McElroy, S.P.; Gurney, A.M.; Drummond, R.M., 2008:
Pharmacological profile of store-operated Ca(2+) entry in intrapulmonary artery smooth muscle cells

Van Der Heyden, J.A.M.; Groenink, L.; Van Der Gugten, J.; Ronken, E.; Zethof, T.; Olivier, B., 1994:
Pharmacological profile of stress-induced hyperthermia paradigm in mice A model for anxiety

Harris, E.W.; Garske, G.C.; Cregan, E.F.; Freedman, L.R.; Palmer, G.C., 1990:
Pharmacological profile of submaximal corneal electroshock kindling lack of involvement of nmda receptors

Sakurada, T.; Sugiyama, A.; Tanno, K.; Sakurada, S.; Ohba, M.; Kisara, K., 1995:
Pharmacological profile of tachykinin NK1 receptor antagonist, substance P

Micheli, D.; Ratti, E.; Toson, G.; Trist, D.; Gaviraghi, G., 1990:
Pharmacological profile of taludipine gr 53992b a new long acting calcium entry blocker

Kimura, M.; Saito, M.; Ishitani, R., 1989:
Pharmacological profile of temperature induced high affinity tritiated tryptamine binding sites

Bartoszyk, G.D.; Boettcher, H.; Greiner, H.E.; Harting, J.; Seyfried, C.A., 1994:
Pharmacological profile of the 5HT-1A-anxiolytic EMD 67478

Bartoszyk, G.D.; Bottcher, H.; Greiner, H.; Harting, J.; Seyfried, C.A., 1991:
Pharmacological profile of the 5ht 1a anxiolytic emd 56551

Bartoszyk, G.D.; Greiner, H.E.; Harting, J.; Stohrer, M.; Seyfried, C.A., 1992:
Pharmacological profile of the atypical neuroleptic drug EMD 57445

Laruelle, M.; Sidhu, A.; Casanova, M.; Weinberger, D.R.; Kleinman, J.E., 1989:
Pharmacological profile of the binding of iodine 125 labeled sch 23982 in human brain

Doods, H.N., 1989:
Pharmacological profile of the cardioselective antimuscarinic compound af dx 384

Colquhoun, L.; Holden Dye, L.; Walker, R.J., 1991:
Pharmacological profile of the cholinoceptor on the somatic muscle cells of the parasitic nematode ascaris suum

Caldwell, L.; Mezu, A.; Ranson, T.; Lancaster, J.; Barron, K.; Zimmerer, L.; Kinnier, W.J.; Sweetnam, P.M., 1992:
Pharmacological profile of the leaf extract from the neurolaena lobata plant

Wenzel, M.; Amdahl, L.; Goodrum, D.; Garst, M.; Harcourt, D.; Holmes, J.; Lee, G.; Syage, E.; Devries, G.; Wheeler, L., 1989:
Pharmacological profile of the marine natural product manoalide

Bartoszyk, G.D.; Barber, A.; Boettcher, H.; Greiner, H.E.; Leibrock, J.; Martinez, J.M.; Seyfried, C.A., 1996:
Pharmacological profile of the mixed 5HT-re-uptake inhibitor/5HT-1A-agonist EMD 68843

Wood, I.C.; Caulfield, M.P.; Buckley, N.J.; Brown, D.A., 1992:
Pharmacological profile of the muscarinic receptor in a mouse neuroblastoma n18tg2 which expresses the m 4 muscarinic receptor gene

Janssen, P.A.J.; Schellekens, K.H.L.; Niemegeers, C.J.E.; Awouters, F.H.L.; Megens, A.A.H.P., 1990:
Pharmacological profile of the new benzisoxazolyl neuroleptic r 79 598

Sasaki, Y.; Hosoe, H.; Sugiyama, N.; Ohshima, E.; Nonaka, H.; Miki, I.; Ishii, A.; Ohmori, K., 1992:
Pharmacological profile of the optical isomers of kw 4099 a novel antiallergic drug with txa 2 antagonistic activity

Kondo, A.; Soong, T.W.; Mbungu, D.N.; Olivera, B.M.; Snutch, T.P.; Adams, M.E., 1994:
Pharmacological profile of the rat alpha-1E calcium channel subunit expressed in Xenopus oocytes

Friedman, D.J.; Krause, D.N.; Duckles, S.P., 1991:
Pharmacological profile of the selective d 2 dopamine agonist n 0923

Yoshida, N.; Omoya, H.; Une, T.; Ito, T.; Kato, S., 1991:
Pharmacological profile of the stereoisomers of as 5370 a novel 5 ht 3 receptor antagonist

Sheardown, M.J.; Hansen, A.J.; Valsborg, J.S.; Thomsen, C.; Weis, J.U.; Judge, M.E.; Knutsen, L.J.S., 1997:
Pharmacological profile of the stroke drug candidate, 2-chloro-N- thio-2-propyladenosine

Arnold, D.J.; CrumbWilliam, J.Jr.; Brown, A.M.; Wible, B., 1994:
Pharmacological profile of two human cardiac potassium channels

Schewe, T.; Kuehn, H.; Loose, S.; Luecke, L., 1991:
Pharmacological profile pharmacokinetics and biotransformation of the 5 lipoxygenase inhibitor flm 5011

Yoshikawa, T.; Yoshida, N.; Omoya, H.; Kato, S.; Hosoki, K., 1997:
Pharmacological profiles of AD-8112, a novel dopamine D-3 and serotonin 5-HT-3 receptors antagonist

Baba, A.; Hoshino, E.; Onoma, M.; Esaki, T.; Takeda, K., 1995:
Pharmacological profiles of AG-041R, a novel selective gastrin/CCK-B antagonist

Sugimoto, M.; Kozuka, M.; Kondo, Y.; IIzawa, T.; Niitsu, Y.; Sakai, J.; Nagano, M.; Iwata, N., 1998:
Pharmacological profiles of CS-932, a functionally selective M1 agonist

Ogihara, Y.; Honda, Y.; Shimoto, Y., 1997:
Pharmacological profiles of D51-9927, a novel gastrin receptor antagonist

Tomita, M.; Nagashima, A.; Sogabe, K.; Shimomura, K., 1997:
Pharmacological profiles of FR161282, a new, nonpeptide vasopressin V2 receptor antagonist

Shinyama, H.; Ebisu, H.; Nishikawa, M.; Egi, Y.; Okazoe, T.; Morizawa, Y.; Imagawa, T.; Nakamura, N., 1998:
Pharmacological profiles of GA0113, a novel quinoline derivative angiotensin II AT1 receptor antagonist

Kato, M.; Nakamura, S.; Ishikawa, T.; Yanaka, M.; Hidaka, H., 1997:
Pharmacological profiles of HFV-1017C, a novel anti-thrombosis agent

Ikegawa, R.; Imada, T.; Tsuruzoe, N.; Shudo, N.; Nakamura, N., 1995:
Pharmacological profiles of NM-702, a novel multiple inhibitor of cyclic-nucleotide phosphodiesterases and thromboxane A-2 synthase

Zieminska, E.; Salinska, E.; Stafiej, A.; Lazarewicz, J.W., 1995:
Pharmacological profiles of NMDA-induced eicosanoid release in rabbit hippocampus in vivo

Goto, J.; Yamane, Y.; Ikeda, T.; Toda, Y.; Tsuchida, K.; Higuchi, S., 1998:
Pharmacological profiles of TS-943, a novel platelet GPIIb/IIIa antagonist in vitro

Amano, H.; Tamura, K.; Okuhira, M.; Inokuma, K.I.hi; Nomiyama, J.; Nishimura, K.; Hirata, T.; Hashimoto, K., 1994:
Pharmacological profiles of WK-1492, a new nonpeptide angiotensin II receptor antagonist

Masuda, N.; Uchida, W.; Arai, Y.; Taguchi, T.; Tsuzuki, R.; Inagaki, O.; Takenaka, T., 1993:
Pharmacological profiles of YM099, a new potassium channel opener

Makela, R.; Uusi Oukari, M.; Homanics, G.E.; Quinlan, J.J.; Firestone, L.L.; Wisden, W.; Korpi, E.R., 1997:
Pharmacological profiles of cerebellar GABA-A receptors in alpha-6 subunit knockout and wild type mice

Lønning, P.E., 1998:
Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer

Virtanen, R., 1989:
Pharmacological profiles of medetomidine and its antagonist, atipamezole

Cusack, B.M.; Mccormick, D.; Phung, C.T.; Perry, R.; Pang, Y.P.; Fauq, A.; Richelson, E., 1995:
Pharmacological profiles of newly synthesized neurotensin analogs

Hayashi, H.; Fujii, R., 1995:
Pharmacological profiles of the subtypes of endothelin receptors mediating aggregation of melanosomes in fish melanophores

Hayashi, H.; Fujii, R., 1992:
Pharmacological profiles of the subtypes of muscarinic cholinoceptors that mediate pigment aggregation within melanophores of the mailed catfish, Corydoras paleatus

Uchida, W.; Shibasaki, K.; Matsumoto, Y.; Asano, M.; Fujikura, T.; Takenaka, T.; Honda, K., 1992:
Pharmacological profiles of ym934 a novel potassium channel opener

Escott, K.J.; Mcmillan, S.J.; Birrell, M.; Webber, S.E.; Souness, J.E.; Maslen, C.; Temple, R.; Iqbal, S.; Mariucci, M.; Rose, J.; Geiger, L.E.; Thurairatnam, S.; Bower, S.; Aldous, D.; Sargent, C.A., 1998:
Pharmacological profiling of phosphodiesterase 4 inhibitors and analysis of the therapeutic ratio in rats and dogs

Kaestner, W., 1992:
Pharmacological properties

Scatton, B.; Arbilla, S.; Allen, J.; Dana, C.; Benavides, J., 1990:
Pharmacological properties and autoradiographic distribution of the binding of tritium labelled sl 85 0324 a nonsedative h 1 receptor antagonist in the guinea pig brain

Mashkovskii, M.D.; Trubitsyna, T.K.; Skachilova, S.Ya; Golubeva, M.I.; Shashkina, L.F.; Absava, G.I., 1989:
Pharmacological properties and clinical study of dopamine

Savko, V., 1990:
Pharmacological properties and clinical use of cefoperazone

Ruat, M.; Traiffort, E.; Arrang, J.M.; Leurs, R.; Diaz, G.; Enjalbert, A.; Tardivel Lacombe, J.; Schwartz, J.C., 1993:
Pharmacological properties and localization of a novel cloned rat serotonin receptor

Doroshenko, P.A.; Woppmann, A.; Miljanich, G.; Augustine, G.J., 1993:
Pharmacological properties and localization of calcium channel types in the cerebellar cortex

Stutzmann, J.M.; Piot, O.; Reibaud, M.; Doble, A.; Blanchard, J.C., 1992:
Pharmacological properties and mechanism of action of the cyclopyrrolones

Al'tshuler R.A.; Marchenko, V.I., 1990:
Pharmacological properties and medical application of reaferon

Kozlovskaya, M.M.; Nikitin, S.V.; Gochmuradov, A.; Smirnov, L.D., 1994:
Pharmacological properties and specific psychotropic activity of new derivatives of heterocyclic phenols with a bridge nitrogen atom

Avenet, P.; Letang, V.; Ruano, D.; Biton, B.; Vitorica, J.; Depoortere, H.; Benavides, J.; Scatton, B., 1997:
Pharmacological properties and subunit composition of rat spinal cord GABA-A receptors assessed by patch-clamping and single cell multiplex RT-PCR

Suzuki, T.; Yamamoto, T.; Abe, S.; Hori, T.; Moroji, T.; Shiraishi, H.; Ito, T.; Ho, I.K., 1994:
Pharmacological properties of 3-OH-PCP binding sites in rat brain by autoradiographic studies

Billard, J.M.; Jouvenceau, A.; Potier, B.; Lamour, Y.; Dutar, P., 1997:
Pharmacological properties of CA1 pyramidal cells in the aged rat

Noguchi, H.; Kitazumi, K.; Mori, M.; Shiba, T.; Nishiki, K., 1996:
Pharmacological properties of CL284,846, a new nonbenzodiazepine sedative-hypnotic

Shirota, H.; Chiba, K.I.hi; Goto, M.; Katayama, K.; Yamatsu, I., 1994:
Pharmacological properties of E5090 An orally active inhibitor of interleukin-1 generation

Nishikawa, M.; Ishida, N.; Gohda, M.; Okazoe, T.; Morizawa, Y.; Uchida, T.; Nakamura, N.; Watanabe, M., 1994:
Pharmacological properties of GA0056, a novel, highly selective angiotensin II receptor antagonist

Liu, Y.; Lasater, E.M., 1996:
Pharmacological properties of GABA-A and GABA-C receptors in turtle retinal ganglion cells

Mackenzie, Andrew, R., 1994:
Pharmacological properties of IX 207-887

Kiguchi, S.; Aoyagi, S.; Ichikawa, K.; Kojima, M.; Arita, H., 1998:
Pharmacological properties of KIN-493 produced antinociception in STZ-induced diabetic mice

Ishibashi, T.; Imai, S., 1994:
Pharmacological properties of KRN2391

Ishikawa, T.; Sano, T.; Furuta, S.; Aikawa, N.; Yamada, K., 1994:
Pharmacological properties of KW-3433, a new angiotensin II receptor antagonist

Nakamura, S.; Shirahase, H.; Kamiya, S.; Yoshimi, A.; Matsui, H.; Kurahashi, K., 1995:
Pharmacological properties of KY-331, a new ACAT inhibitor with anti-peroxidative activity

Dickinson, K.E.J.; Cohen, R.B.; Bird, J.E.; Waldron, T.L.; Schaeffer, T.R.; Moreland, S.; Delaney, C.L.; Serafino, R.; Poss, M.A., 1992:
Pharmacological properties of MBS 180560, an insurmountable angiotensin II receptor antagonist

Nakamaru, K.; Sugai, T.; Sato, M.; Taniguchi, S.; Tanaka, Y.; Kawase, S., 1994:
Pharmacological properties of N-5ASA , an agent for inflammatory bowel disease

Fujibayashi, K.; Sakamoto, K.; Watanabe, M.; IIzuka, Y., 1994:
Pharmacological properties of R-84760, a novel kappa-opioid agonist

Bohme, G.A.; Bertrand, P.; Piot, O.; Boudeau, P.; Jeantaud, B.; Pauchet, C.; Guyon, C.; Manfre, F.; Imperato, A.; Dubroeucq, M.C., 1997:
Pharmacological properties of RPR 102681, A novel CCK-B antagonist

Itakura, Yuka; Tsukamoto, Katsura; Nakamura, Shigeyoshi; Mineta, Koji; Takeda, Motohiro; Ozeki, Yoshiro, 1996:
Pharmacological properties of SKK-47029, a new serotonin -4 receptor agonist

Yamamoto, T.; Fukuda, T.; Hirohashi, T.; Hara, Y., 1993:
Pharmacological properties of SM-10902, a new stable prostaglandin I1 analogue

Furuhata, K.; Todo, Y.; Takakura, T.; Watanabe, Y.; Narita, H., 1998:
Pharmacological properties of T-3762, a novel fluoroquinolone antimicrobial agent in parenteral use III 1a,b Chemical structures and dermovascular permeability-increasing activities

Kitamura, H.; Morimoto, K.; Kasukawa, H.; Ohnishi, H.; Kamibayashi, M.; Okamoto, K.; Kamitani, T., 1994:
Pharmacological properties of TER930180, a dual inhibitor of thromboxane A-2 receptor and TxA-2 synthase

Fujimori, A.; Shibasaki, M.; Tokioka, T.; Kusayama, T.; Takanashi, M.; Inagaki, O.; Okazaki, T.; Yanagisawa, I.; Takenaka, T., 1993:
Pharmacological properties of YM358, a novel, selective and competitive AT-1 receptor antagonist

Fukuda, Y.; Fukuta, Y.; Yoshida, K.; Higashino, R.; Ogishima, M.; Takei, M.; Kurimoto, T.; Tanaka, Y.; Tamaki, H., 1998:
Pharmacological properties of Z-350, which possesses alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory actions In vitro studies

Fukuta, Y.F.kuta; Fukuda, Y.; Higashino, R.; Yoshida, K.; Ogishima, M.; Furuta, S.; Kamata, E.; Mayahara, H.; Takei, M.; Kunimoto, T.; Tanaka, Y.; Tamaki, H., 1998:
Pharmacological properties of Z-350, which possesses alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory actions In vivo studies

Gotzes, F.; Balfanz, S.; Baumann, A., 1995:
Pharmacological properties of a Drosophila melanogaster dopamine receptor

Yanagisawa, M.; Hosoki, R.; Otsuka, M., 1991:
Pharmacological properties of a c fiber response evoked by stimulation of greater splanchnic nerve in an associated spinal cord nerve preparation of the newborn rat

Kato, M.; Saito, N.; Win, N.H.a Hla; Hidaka, H., 1996:
Pharmacological properties of a new and potent calmodulin antagonist, HF2035

Yamaji, Y.; Tanaka, T.; Araki, T.; Seiki, M.; Tagashira, E.; Okabe, S., 1992:
Pharmacological properties of a new anti ulcer drug z 300 studies of histamine h 2 receptor antagonism

Bercher, H.; Grisk, A., 1989:
Pharmacological properties of a new beta 1 receptor blocking agent with vasodilating action

Manabe, H.; Kuroda, T.; Ohno, T.; Ichimura, M.; Suzuki, F.; Kase, H.; Kitamura, S.; Ohmori, K., 1992:
Pharmacological properties of a new bronchodilator kf17625

Manabe, H.; Ohnuma, K.; Ichimura, M.; Kawakita, T.; Suzuki, F.; Ohmori, K., 1995:
Pharmacological properties of a new bronchodilator, KF19514

Kloosterboer, H.J.; Deckers, G.H.; de Gooyer, M.E.; Dijkema, R.; Orlemans, E.O.; Schoonen, W.G., 1995:
Pharmacological properties of a new selective antiprogestagen: Org 33628

Hosoki, R.; Nizawa, S.; Koike, K.; Takayanagi, I.; Sagara, T.; Kanematsu, K., 1996:
Pharmacological properties of a newly synthesized 10-oxo derivative of N-cyclopropylmethyl -6 beta-acetylthiodihydronormorphine

Shinguh, Y.; Yamazaki, A.; Inamura, N.; Nakahara, K.; Notsu, Y.; Okamoto, M.; Okuhara, M.; Henmi, K.; Tanaka, H.; Ono, T., 1993:
Pharmacological properties of a novel and potent elastase inhibitor, FR134043

Shimojo, M.; Takasugi, K.; Yamamoto, I.; Funato, H.; Mochizuki, H.; Kohsaka, S., 1997:
Pharmacological properties of a novel neuroprotective agent-M50463 derivatives in primary cultured neurons

Price, C.J.; Goldberg, J.I., 1993:
Pharmacological properties of a serotonin-activated sodium current in an identified neuron from Helisoma trivolvis

Yanagisawa, M.; Hosoki, R.; Otsuka, M., 1993:
Pharmacological properties of a slow C-fiber response induced by stimulation of greater splanchnic nerve in an isolated spinal cord-nerve preparation of the newborn rat

Yanagisawa, M.; Otsuka, M., 1989:
Pharmacological properties of a slow c fiber response induced by saphenous nerve stimulation in an isolated spinal cord nerve preparation of the newborn rat

Schwabe, U.; Fein, T.; Lorenzen, A., 1993:
Pharmacological properties of adenosine receptors and adenosine binding proteins

Kimura, C.; Katsumata, S.; Ienaga, Y.; Minami, M.; Satoh, M., 1997:
Pharmacological properties of agonist-antagonist analgesics in development of dependence and precipitation of withdrawal in CHO cells expressed the cloned opioid receptors

Belozertseva, E.G.; Frolova, N.Y.; Chakchir, B.A.; Solod, O.V.; Zelenin, K.N., 1998:
Pharmacological properties of alkylidene derivatives of benzamidrazonium salts

Hajos, M.; Villa, A.E.P.; Sharp, T., 1996:
Pharmacological properties of burst-firing serotonergic neurones in the rat dorsal raphe nucleus

Watanabe, Y.; Zhang X Q.; Izumisawa, M.; Matsumiya, T.; Shibuya, T., 1990:
Pharmacological properties of calcium channel antagonists in the central nervous system cns

Delvaux, M.; Berry, P.; More, J.; Frexinos, J.; Bueno, L., 1990:
Pharmacological properties of cck gastrin receptor on isolated smooth muscle cells from pig ileum

Christ, W., 1991:
Pharmacological properties of cephalosporins

Yoshimoto, H.; Nagano, N.; Nishitoba, T.; Sato, H.; Miyata, S.; Kusaka, M.; Jing, S.B.ng; Yamaguchi, T., 1995:
Pharmacological properties of chitosan-coated dialdehyde cellulose , a newly developed oral adsorbent Effect of chitosan DAC in normal rats

Nagano, N.; Yoshimoto, H.; Nishitoba, T.; Sato, H.; Miyata, S.; Kusaka, M.; Jing, S.B.ng; Yamaguchi, T., 1995:
Pharmacological properties of chitosan-coated dialdehyde cellulose , a newly developed oral adsorbent Effect of chitosan DAC on rats with chronic renal failure induced by adriamycin

Ao, S.; Aramori, I.; Kojo, H.; Sasaki, H.; Notsu, Y., 1997:
Pharmacological properties of cloned human VIP1, VIP2 and PACAP receptors in stably expressed CHO cells

Sakamoto, A.; Yanagisawa, M.; Sakurai, T.; Nakao, K.; Imura, H.; Masaki, T., 1992:
Pharmacological properties of cloned human endothelin receptor subtypes

Schoepp, D.D.; Johnson, B.G.; Desai, M.A.; Mayne, N.; Burnett, J.P., 1995:
Pharmacological properties of cloned human metabotropic glutamate receptors

Andreeva, N.I.; Asnina, V.V.; Parshin, V.A.; Mashkovskii, M.D., 1998:
Pharmacological properties of digam, a new potential nootropic agent

Wafford, K.A.; Bain, C.J.; L.B.urdelles, B.; Whiting, P.J.; Kemp, J.A., 1993:
Pharmacological properties of double and triple heteromeric NMDA receptor combinations

Eppenberger, U.; Hasmann, M.; Kueng, W.; Wosikowski, K.; Seibel, K.; Loeser, R., 1990:
Pharmacological properties of droloxifene drol

Shirota, H.; Chiba, K.; Goto, M.; Hashida, R.; Ono, H.; Okita, M.; Sakurai, H.; Machida, Y.; Yamatsu, I.; Katayama, K., 1990:
Pharmacological properties of e 5090 a novel orally active inhibitor of il 1 generation

Bothe, G.; Miyan, J.A., 1992:
Pharmacological properties of eclosion muscles in sarcophaga bullata

Arens, J.; Stabel, J.; Heinemann, U., 1992:
Pharmacological properties of excitatory amino acid induced changes in extracellular calcium concentration in rat hippocampal slices

Monreal, M.; Costa, J.; Salva, P., 1996:
Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin

Yamaguchi, T.; Tsujii, T.; Azuma, H.; Oshima, H., 1991:
Pharmacological properties of human benign prostatic hypertrophy bph

Ohashi, H.; Saba, E.; Komori, S.; Takewaki, T., 1993:
Pharmacological properties of inhibitory junction potentials in avian gizzard muscle

Van Eyseren, I.; Tihao, F.; L.G.en, J.; Pichon, Y., 1997:
Pharmacological properties of ionotropic acetylcholine receptors in developing insect neurones in primary culture

Zukin, R.S.; Roginski, R.S.; Mcgurk, J.; Bennett, M.V.L., 1990:
Pharmacological properties of kainate activated channels expressed from a rat brain complementary dna

Kosakai, K.; Wakabayashi, S.; Satoh, T.; Tomiyama, A.; Satake, N.; Shibata, S., 1991:
Pharmacological properties of kt 2 962 an azulene derivative a novel txa 2 pgh 2 antagonist

Sasaki, Y.; Ishii, H.; Oshima, E.; Obase, H.; Kitamura, S.; Ohmori, K., 1990:
Pharmacological properties of kw 4099 a new antiallergic agent with txa 2 antagonist activity

Shimaji, H.; Hashizume, Y.; Matsui, H.; Kamiya, S.; Shirahase, H., 1992:
Pharmacological properties of ky 063 a novel txa 2 synthetase inhibitor with potent antiperoxidative activity

Juhasz, A.; Haynes, L.W.; Barnes, S., 1993:
Pharmacological properties of low-voltage activated Ca channels in undifferentiated human retinoblastoma cells

Kobrinsky, E.M.; Pearson, H.A.; Dolphin, A.C., 1993:
Pharmacological properties of low-voltage-activated calcium channel currents in the dorsal root ganglion cell X neuroblastoma hybrid cell line, ND7-23

Masumiya, H.; Tateyama, M.; Ochi, R., 1997:
Pharmacological properties of manganese currents in rabbit ventricular myocytes

Schoepp, Darryle, D., 1994:
Pharmacological properties of metabotropic glutamate receptors

Lovinger, D.M.; Choi, S.; Mccool, B.A., 1994:
Pharmacological properties of metabotropic glutamate receptors which inhibit synaptic transmission and voltage-gated calcium currents

Takayanagi, I.; Koike, K.; Suzuki, T., 1990:
Pharmacological properties of newly synthesized derivatives of levo 6 beta acetylthionormorphine and their the interactions with opioid receptors

Gravenstede, S.L.; Nolan, M.F.; Spanswick, D.; Logan, S.D., 1998:
Pharmacological properties of non-NMDA ionotropic glutamate receptors in sympathetic preganglionic neurones

Serafin, M.; Muhlethaler, M., 1992:
Pharmacological properties of nucleus gigantocellularis neurons A in vitro study in guinea pig brainstem slices

Tsukamoto, M.; Kondo, S.; Yokoo, N.; Nakamura, M.; Uchida, Y., 1990:
Pharmacological properties of optical isomers of nipradilol

Mulqueen, M.J.; Watkins, A.M.; Dunford, P.J.; Kai In, P.W.ng; Thomas, G.; Lambert, R.W.; Parkes, K.E.B.; Merett, J.H.; Malcolm, S.A.; Roberts, N.A.; Martin, J.A., 1997:
Pharmacological properties of orally active inhibitors of herpes simplex virus thymidine kinase

Hitzenberger, G.; Rameis, H.; Manigley, C., 1998:
Pharmacological properties of piracetam Rationale for use in stroke patients

Baldus, B.; Donner, P.; Schleuning W D., 1990:
Pharmacological properties of plasminogen activators from the saliva of desmodus rotundus

Carl, A.; Du, C.; Kenyon, J.L.; Keef, K.D.; Sanders, K.M., 1993:
Pharmacological properties of potassium currents in isolated canine colonic myocytes

Shimizu, T.; Yoshimura, M.; Nishi, S., 1994:
Pharmacological properties of primary afferent depolarization in adult rat spinal cord slices

Yano, K.; Morimoto, H.; Morita, M.; Tanabe, T.; Watanabe, M.; Yokoyama, K., 1993:
Pharmacological properties of prourokinase mutants having amino acid substitution in EGF-like domain

Graham, D.; Avenet, P.; Faure, C.; Granger, P.; Depoortere, H.; Langer, S.Z., 1994:
Pharmacological properties of recombinant rat GABA-A receptor subtypes

Bian, J.T.; Lazrak, A.; Houamed, K.M., 1997:
Pharmacological properties of recombinant small-conductance calcium-activated potassium channels expressed in a mammalian cell line

Miyawaki, N.; Nishimura, K.; Setoguichi, C.; Yamauchi, H., 1990:
Pharmacological properties of sd 3211 a novel calcium antagonist in the electrical and mechanical responses of isolated hearts and vessels

Noack, E.; Behne, M.; Kojda, G., 1992:
Pharmacological properties of spm 3672 a nitrovasodilator directly liberating nitric oxide

Nisato, D.; Cazaubon, C.; Lacour, C.; Gougat, J.; Guiraudou, P.; Bernhart, C.; Perreaut, P.; Breliere, J.C.; L.F.r G., 1992:
Pharmacological properties of sr 47436 a non peptidic angiotensin ii receptor antagonist

Tripathi, V.; Acharya, S.B.; Tripathi, Y.B., 1991:
Pharmacological properties of terminalia arjuna

Bachmann, A.; Russ, U.; Busch, A.E.; Waldegger, S.; Quast, U., 1998:
Pharmacological properties of the Cl- channel, CFTR

Duffy, S.; Fraser, D.D.; Hoppe, D.; Kettenmann, H.; Macvicar, B.A., 1992:
Pharmacological properties of the GABA-A receptor of acutely isolated hippocampal astrocytes

Bentareha, R.; Araujo, F.; Ruano, D.; Driscoll, P.; Escorihuela, R.M.; Tobena, A.; Fernandez Teruel, A.; Vitorica, J., 1998:
Pharmacological properties of the GABAA receptor complex from brain regions of Roman high- and low-avoidance rats

Bleakman, D.; Brust, P.F.; Bowman, D.; Grantham, C.J.; Ellis, S.B.; Miller, R.J.; Harpold, M.M., 1993:
Pharmacological properties of the N-type VSCC in transfected HEK 293 cells

Khakimov, D.A.; Aliev, K.U.; Yuldashev, A.Kh, 1990:
Pharmacological properties of the complex compound of zinc 67 and a bioactive substances

Auch Schwelk, W.; Katusic, Z.S.; Vanhoutte, P.M., 1990:
Pharmacological properties of the contracting factor released by the endothelium in the shr aorta

Silverio,M.S.; Sousa,O.V.; Vechio-Vieira,G.del; Miranda,M.A.; Matheus,F.C.; Kaplan,M.A.C., 2008:
Pharmacological properties of the ethanol extract from Eremanthus erythropappus McLeisch

Ballivet, M.; Bertrand, S.; Bertrand, D., 1991:
Pharmacological properties of the homo oligomeric neuronal nicotinic acetylcholine receptor a7

Seiler, N., 1991:
Pharmacological properties of the natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach

Biazzari, J.P.; Cour, V.; Bruch, M., 1990:
Pharmacological properties of the new anti cancer drug fotemustine clinical implications

Kemp, D.E.; Weiss, S., 1989:
Pharmacological properties of the nmda receptor system coupled to the evoked release of tritiated gaba from striatal neurons in primary culture

Cheon, H.G.; Kim, H.J.; Kim, Y.C.; Kong, J.Y., 1997:
Pharmacological properties of the novel gastric H+/K+ ATPase inhibitor, KR 60254

Shinkawa, T.; Yamasaki, F.; Kikuchi, A.; Nakakuki, M.; Nishijima, K.; Uemura, A.; Mizota, M.; Orita, Y., 1992:
Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1- -4 -quinolinone 4-oxime-O-sulfonic acid potassium salt

Clarke, D.E.; Baxter, G.S.; Young, H.; Craig, D.A., 1991:
Pharmacological properties of the putative 5 ht 4 receptor in guinea pig ileum and rat oesophagus role in peristalsis

Crunelli, V.; Erdemli, G., 1997:
Pharmacological properties of the response of thalamocortical neurones to brief hypoxia

Mueller, Walter, E., 1997:
Pharmacological properties of the specific serotonin and norepinephrine reuptake inhibitor Venlafaxine

Kalix, P., 1990:
Pharmacological properties of the stimulant khat

Nakamura, I.; Ozawa, Y.; Sakitama, K., 1997:
Pharmacological properties of the tonic vibration reflex in the masseter muscle and the tonic periodontal masseteric reflex in rat

Ojewole, J.A.O.; Rogers, C.B., 1998:
Pharmacological properties of triterpenoid molluscicides from African Combretaceae

Ueno, S.; Takahashi, K.; Akaike, N., 1990:
Pharmacological properties of ttx sensitive calcium current in isolated rat hippocampal neurons

Saitoh, N.; Ishikawa, T.; Watanabe, Y.; Kobayashi, R.; Hidaka, H., 1991:
Pharmacological properties of w 66 a novel vasorelaxant

Uchida, W.; Takizawa, K.; Takizawa, K.; Asano, M., 1990:
Pharmacological properties of ym 15430 1 1 4 dihydropyridine derivative with beta 1 adrenoceptor blocking activity

Tomioka, K.; Yamada, T.; Mase, T.; Tsuzuki, R.; Hara, H.; Murase, K., 1989:
Pharmacological properties of ym 17551 an orally active leukotriene antagonist

Yazawa, H.; Hiramoto, M.; Imai, H.; Honda, K., 1992:
Pharmacological properties of ym 21170 a novel superoxide anion scavenger from pseudonocardia sp q1047

Ito, H.; Miyata, K.; Kamato, T.; Nishida, A.; Tsutsumi, R.; Yuki, H.; Yamano, M.; Honda, K., 1991:
Pharmacological properties on ym 060 a potent and selective serotonin 5ht3 receptor antagonist and its enantiomer in the isolated tissue

Awane, Yumiko; Kusumoto, Keiji; Hashiguchi, Shouhei; Shiraishi, Mitsuru; Watanabe, Toshifumi, 1993:
Pharmacological property of a new potassium channel opener, TCV-295 in vitro

Marullo, M.; Giuffre, I.; D.F.lice, N.; Scupola, A.; Simi, G.; Balestrazzi, E., 1997:
Pharmacological prophylaxis of fibrinous exudation in vitreo-retinal surgery

Moos, W.H.; Davis, R.E.; Gamzu, E.R., 1992:
Pharmacological prospectives

Herman, E.H.; Ferrans, V.J., 1995:
Pharmacological protection against pulmonary toxicity resulting from antineoplastic drug therapy

Grenhoff, J.; Tung C S.; Svensson, T.H., 1989:
Pharmacological protection against the effect of reversible hypofrontality on rat midbrain dopamine neurons in vivo

Kinzirskii, A.S., 1995:
Pharmacological protection of the body from metastases

Kenakin, T., 1995 :
Pharmacological proteus?

Ascensao, J.L.; Marusic, M.; Fallon, M.; Gaffney, J.; Bergstrom, S.; Mukherji, B., 1990:
Pharmacological purging of bone marrow bm with 4 hydroxyperoxycyclophosphamide 4 hc effect on lymphoid cells

Sawynok, J., 1995:
Pharmacological rationale for the clinical use of caffeine

Kempinas, W.G.; Pereira, O.C.; Melo, V.R.; Carvalho, T.L., 1991:
Pharmacological reactivity of rat vas deferens in chronic and subacute lead intoxication

Hourani, S.M.; Cusack, N.J., 1991:
Pharmacological receptors on blood platelets

Green, J.P., 1990:
Pharmacological receptors: the need for a compendium of classification, nomenclature and structure

George, D.T.; Moss, H.; Martin, P.; Linnoila, M., 1990:
Pharmacological reduction of alcohol consumption

Johansson, B.B.; Westergren, I., 1994:
Pharmacological reduction of brain edema induced by intracarotid infusion of protamine sulphate: a comparison between a free radical scavenger and an AMPA receptor antagonist

Nishiwaki, H.; Miyamoto, K.; Matsuda, N.; Ogura, Y., 1996:
Pharmacological reduction of interferon-induced leukocyte trapping in retinal microcirculation

Jarvis, W.D.; Dent, P.; Grant, S., 1998:
Pharmacological reductions of PKC and/or MAPK potentiate the apoptotic capacity of 1- cytosine , but not 2,2-diflurodeoxycytidine

Fuller, R.W., 1991:
Pharmacological regulation of airway macrophage function

Pisarev, V.M.; Gaponov, A.M.; Tutel'yan, A.V.; Danilina, A.V.; Pevnitskii, L.A.; Lebedev, V.V., 1996:
Pharmacological regulation of antiproliferative effect of corticosteroid hormones

Patil, R.V.; Han, Z.; Yang, X.; Wax, M.B., 1997:
Pharmacological regulation of aquaporin 1

White, H.S.; Skeen, G.A.; Edwards, J.A., 1992:
Pharmacological regulation of astrocytic calcium channels: implications for the treatment of seizure disorders

Sato, F.; Soos, G.; Kane, N.; Sato, K., 1995:
Pharmacological regulation of eccrine sweat gland cell growth in culture

O.Ishi, Sachiko, 1996:
Pharmacological regulation of inducible functionally active molecules

Klebanov, B.M., 1992:
Pharmacological regulation of inflammation Current problems and prospects for development

Baldino, F.Jr.; Lapchak, P.A.; Hartpence, K.; Robbins, E.; Saporito, M.S.; Vaught, J.L.; Wilcox, H.; Carswell, S., 1993:
Pharmacological regulation of neurotrophin mRNA expression in the CNS Application to the attenuation of age- and lesions-induced cholinergic neurodegeneration

Abbadie, C.; Trafton, J.A.; Marchand, S.; Wang, H.; Mantyh, P.W.; Basbaum, A.I., 1997:
Pharmacological regulation of noxious stimulus evoked internalization of the neurokinin-1 receptor in the dorsal horn of the rat spinal cord

Shashkov, V.S., 1990 :
Pharmacological regulation of physiological functions in space medicine

Acquas, E.; Fibiger, H.C., 1996:
Pharmacological regulation of sensory stimulation-evoked increases in cortical acetylcholine release

Sato, K.; Ohtsuyama, M.; Sato, F., 1992:
Pharmacological regulation of sweat ductal function as studied by whole cell voltage/current clamp methods

Kurachi, Y.; Terzic, A.; Findlay, I., 1996:
Pharmacological regulation of the cardiac ATP-sensitive K+ channel

Mirzoyan, R.S., 1995:
Pharmacological regulation of the cerebral circulation

Chang, C.C.; Naiki, M.; Halpern, G.M.; Gershwin, M.E., 1993:
Pharmacological regulation of the immune system

Nagakura, T.; Obata, T.; Yamashita, Y.; Sakurai, M.; Kanbe, M.; Masaki, T.; Maekawa, K., 1997:
Pharmacological regulation on IgE-induced PGD-2 generation and release from cultured human mast cells

Mestre, M.; Hardy J C.; Escande, D.; Cavero, I., 1989:
Pharmacological relevance in animal models of a pure class iii antiarrhythmic agent

Fozard, J.R., 1992:
Pharmacological relevance of 5 ht 3 receptors

Collet, J.P.ilippe; Lesty, C.; Mishal, Z.; Soria, J.; Soria, C.; Thomas, D.; Montalescot, G., 1998:
Pharmacological remodeling of platelet-rich clot architecture by abciximab may explain its dethrombotic efficacy

Collet, J.P.; Soria, C.; Mirshahi, M.; Mishal, Z.; Lesty, C.; Thomas, D.; Montalescot, G.; Soria, J., 1998:
Pharmacological remodeling of platelet-rich clots architecture by ABCIXIMAB may explain the mechanism of its curative antithrombotic effect

Giacobini, E.; Becker, R., 1991:
Pharmacological replacement of cholinergic function in alzheimers disease

Horackova, M.; Huang, M.H.; Armour, J.A., 1993:
Pharmacological responses of adult guinea-pig cardiomyocytes co-cultured with cardiac neurons

Vanderwinden, J.M.; D.L.et, M.H.; Vanderhaeghen, J.J., 1997:
Pharmacological responses of infantile hypertrophic pyloric stenosis in vitro

Kiguchi, M.; Wada, R.; Kawamura, K., 1994:
Pharmacological responses of nifedipine granula administered orally in different ways in rats

Hitri, A.; Wyatt, R.J., 1994:
Pharmacological responsiveness of GBR 12935 binding sites in the prefrontal cortex of cocaine using humans and rats

Katz, R.J.; Landau, P.; DeVeaugh-Geiss, J.; Hakkarainen, H., 1990:
Pharmacological responsiveness of dermatitis secondary to compulsive washing

Hyland, L.; Smeeton, I.; Paton, D.M., 1989:
Pharmacological responsiveness of human coronary arteries relationship to age and disease

Breslin, E.; Teoh, T.G.; Darling, M.; Docherty, J.R., 1992:
Pharmacological responsiveness of human umbilical vessels from normal and pre eclamptic pregnancies

Scobie, N.J.; Szabadi, E.; Bradshaw, C.M., 1991:
Pharmacological responsiveness of the iris and sweat glands in chronic alcoholics

Dilsaver, S.C.; Del Medico, V.J.; Quadri, A.; Jaeckle, S., 1990:
Pharmacological responsiveness of winter depression

Wilberger, James, E.Jr, 1993:
Pharmacological resuscitation after spinal cord injury

Carre, A., 1998:
Pharmacological role of the atenolol/nifedipine combination in hypertensive patients

Verweij, J.; D.V.ies A.; Nooter, K., 1990:
Pharmacological sanctuary ps for drugs with high dna affinity in the bone marrow of brown norway bn rats with acute leukemia bnml

Etetim,E.N.; Useh,M.F.; Okokon,J.E., 2008:
Pharmacological screening and evaluation of antiplasmodial activity of Gongronema latifolium against Plasmodium berghei berghei infection in mice

Moreno, L.; Bello, R.; Beltran, B.; Calatayud, S.; Primo Yufera, E.; Espluques, J., 1998:
Pharmacological screening different Juniperus oxycedrus L extracts

Bigoniya,P.; Shukla,A.; Agrawal,G.P.; Rana,A.C., 2008:
Pharmacological screening of Wrightia tinctoria bark hydro-alcoholic extract

Taesotikul, T.; Panthong, A.; Kanjanapothi, D.; Verpoorte, R.; Scheffer, J.J.C., 1990:
Pharmacological screening of crude alkaloids from tabernaemontana pandacaqui

Cadavid, I.; Laguna, M.R.; Villar, R.; Hernandez, M.C.; Fontenla, J.A.; Calleja, J.M., 1989:
Pharmacological screening of marine algae iv effect on temperature

Fontenla, J.A.; Villar, R.; Laguna, M.R.; Cadavid, I.; Calleja, J.M., 1989:
Pharmacological screening of marine microalgae i effect on contractions induced by acetylcholine and calcium chloride in the rat duodenum

Hernandez, M.C.; Laguna, M.R.; Villar, R.; Fontenla, J.A.; Cadavid, I.; Calleja, J.M., 1989:
Pharmacological screening of marine microalgae ii effect on contractions induced by acetylcholine in the rat duodenum

Villar, R.; Laguna, M.R.; Fontenla, J.A.; Calleja, J.M.; Cadavid, I., 1989:
Pharmacological screening of marine microalgae iii effect on contractions induced by noradrenaline in the rat vas deferens

Scott, G.; Mason, R., 1992:
Pharmacological segregation of visual responses in the dorsolateral geniculate nucleus dlgn of the anaesthetized rat

Harden, T.K.ndall; Nicholas, R.A.; Schachter, J.R.; Lazarowski, E.R.; Boyer, J.L., 1998:
Pharmacological selectivities of molecularly defined subtypes of P2Y receptors

Riva, M.A.; Molteni, R.; Corsini, G.U.; Racagni, G.; Maggio, R., 1998:
Pharmacological selectivity in the modulation of FGF-2 expression within the rat brain

Osipchuk, Y.V.; Ehring, G.R.; Cahalan, M.D., 1994:
Pharmacological sensitivities of volume-activated chloride conductance and rhodamine 123 efflux in drug-sensitive and resistant cell lines

Carmona, G.N.; Goldberg, S.R.; Schindler, C.W., 1996:
Pharmacological sensitization to cocaine depends on similarity between injection and testing conditions

Palmer, A.J.; Zeman, S.; Lodge, D., 1991:
Pharmacological separation between ampa and kainate responses of rat cortical slices by a 2 3 benzodiazepine methohexitone and nickel

Sanchez, D.M.dina, F.; Donowitz, L.H.M.; Tse, C.M., 1998:
Pharmacological separation of NHE2 and NHE3 activity co-expressed in PS120 fibroblasts by HOE694 Evidence that NHE2 and NHE3 do not interact

Roy, J.; Vantol, B.; Cowley, E.A.; Blay, J.; Linsdell, P., 2008:
Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7

Frishman, L.J.; Yamamoto, F.; Bogucka, J.; Steinberg, R.H., 1990:
Pharmacological separation of proximal and distal contributions to the dark adapated erg of cat retina

Lindsley, J.G., 1990:
Pharmacological separation of rem sleep atonia from cataplectic atonia

Mostafapour, S.; Kobilka, B.K.; Von Zastrow, M., 1997:
Pharmacological sequestration of a chimeric beta-3/beta-2 adrenergic receptors occurs without a corresponding amount of receptor internalization

Kimura, Masayasu, 1996:
Pharmacological significance of receptor subtypes including subunit replacement Dual nicotinic receptor system via regulatory Ca-2+ mobilization at neuromuscular synapse

Lowe, V.C.; Jackson, K.N.; Noronha Blob, L., 1990:
Pharmacological similarity between muscarinic receptors mediating mydriasis and salivary gland secretion in guinea pigs

Tian, N.; Slaughter, M.M., 1994:
Pharmacological similarity between the retinal APB receptor and the family of metabotropic glutamate receptors

Bobelis, D.J.; Balster, R.L., 1991:
Pharmacological specificity of drug discrimination based on the n methyl d aspartate antagonist npc 12626

Schindler, C.W.; Goldberg, S.R.; Katz, J.L., 1990:
Pharmacological specificity of enhanced sensitivity to naltrexone in rats

Xiao, L.; Becker, J.B., 1995:
Pharmacological specificity of estrogen-modulated enhancement of amphetamine-induced striatal dopamine release

Maguire, J.J.; Elliott, N.J.; Varney, M.A.; Mcknight, A.T.; Williams, B.J.; Foster, A.C.; Tridgett, R., 1989:
Pharmacological specificity of synthetic peptides as antagonists at tachykinin receptors

Bobelis, D.J.; Balster, R.L., 1993:
Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5- -7-phosphonoheptanoic acid , a competitive N-methyl-D-aspartate receptor antagonist

Tsuneki, H.; Kimura, M.; Kimura, I.; Dezaki, K.; Kondoh, T.; Mitsui K I.; Hidaka, H., 1992:
Pharmacological spectrum of nach receptor activity modulating intracellular calcium ramic related to cellular signalling systems in mouse diaphragm muscles

Tischler, A.S.; Ruzicka, L.A.; Donahue, S.R.; DeLellis, R.A., 1989:
Pharmacological stimulation of chromaffin cell proliferation in the adult adrenal medulla

Scarpignato, C., 1997:
Pharmacological stimulation of gastrointestinal motility: where we are and where are we going?

Kloecking H P., 1990:
Pharmacological stimulation of t pa release from vascular endothelium

Klöcking, H.P.; Markwardt, F., 1994:
Pharmacological stimulation of t-PA release

Van Belle, Eric, 1998 :
Pharmacological stimulation of the angiogenic response in humans A new therapeutic tool?

Kelemen, K.; Marko, R., 1992:
Pharmacological stimulation of the depolarization mechanisms in the heart

Junard, E.O.; Lapchak, P.A.; Jenden, D.J.; Hefti, F., 1992:
Pharmacological stimulation reveals NGF-induced increases of hippocampal cholinergic function measured in vivo in rats with partial fimbrial transections

Mueller, T.H.; Guth, B.D., 1994:
Pharmacological strategies for antithrombotic therapy

Foley, J.E.; Anderson, R.C.; Bell, P.A.; Burkey, B.F.; Deems, R.O.; de Souza, C.; Dunning, B.E., 1997:
Pharmacological strategies for reduction of lipid availability

Lindenmayer J P., 1992:
Pharmacological strategies for the neuroleptic nonresponder

Faden, A.I.; Salzman, S., 1992:
Pharmacological strategies in CNS trauma

Faden, Alan, I., 1995:
Pharmacological strategies in experimental brain trauma

O'Neill, M.; Allain, H.; Bentué-Ferrer, D.; Bellissant, E.; de Certaines, J.; Leonard, B.E., 1995:
Pharmacological strategies in the treatment of cerebral ischemia

Park, C.H.; Kim, S.J.; Pai, M.S.; Kim, H.S., 1997:
Pharmacological stress 201Tl myocardial SPECT using disodium adenosine 5 triphosphate Safety and efficacy study

Willemsen, A.T.M.; Krol, L.; Paans, A.M.J.; Korf, J.; Vaalburg, W., 1995:
Pharmacological stress and visual stimulation effects on normalized regional cerebral blood flow

Underwood, S.R.; Pennell, D.J., 1993:
Pharmacological stress during magnetic resonance imaging

Armstrong, W.F., 1991:
Pharmacological stress echocardiography

O'gorman, D.; D'hondt, A.M.; Vincent, M.; Williams, J.; Marwick, T., 1993:
Pharmacological stress echocardiography identifies vascular surgical patients at risk of cardiac complications

Mazeika, P.K.; Nihoyannopoulos, P.; Nadazdin, A.; Oakley, C.M., 1991:
Pharmacological stress echocardiography in the evaluation of coronary artery disease

Cortigiani, L.; Dodi, C.; Paolini, E.; Iori, E.; Bruno, G.; Nannini, E., 1997:
Pharmacological stress echocardiography versus exercise stress testing to assess prognosis in women with chest pain

Underwood, S.R.; Pennell, D.J.; Rees, R.S.O.; Longmore, D.B., 1990:
Pharmacological stress in the diagnosis and management of coronary artery disease

Bateman, T.M.; O'Keefe, J.H., 1992:
Pharmacological (stress) perfusion scintigraphy: methods, advantages, and applications

Piérard, L.A., 1995:
Pharmacological stress testing and imaging: concluding remarks

Verani, M.S., 1991:
Pharmacological stress with adenosine for myocardial perfusion imaging

Han, Rui, 1994:
Pharmacological studies and clinical application of N- retinamide

Han, J.; L.Y.; G.Q.M., 1992:
Pharmacological studies and clinical application of n 4 carboxyphenyl retinamide r i i for the treatment of premalignancies

Sutoo, D.; Akiyama, K., 1990:
Pharmacological studies central catecholamine synthesis regulation by the calcium calmodulin dependent system

Moroianu, I.; Vizitiu, M.; Coltea, P.; Pop, T., 1996:
Pharmacological studies for the cetil piridinium chloride disinfecting product as an active substance 00026 g tablets and 1 percent solution

Wada, Y.; Yamaguchi, N., 1990:
Pharmacological studies in a new experimental model of photosensitive epilepsy

Stoessl, A.J.; Dourish, C.T.; Iversen, S.D., 1989:
Pharmacological studies in a rodent model of tardive dyskinesia suppression by cholecystokinin cck

Mosca, P.; Lee, F.Y.; Kaumann, A.J.; Groszmann, R.J., 1991:
Pharmacological studies in portal systemic collateral vessels of portal hypertensive rats the role of the endothelium

Ikeda, K.; Ohtsu, T.; Mizuchi, A.; Matsubara, A.; Tanada, H.; Sakai, K., 1991:
Pharmacological studies of 1 3 phenyl 5 isoxazolyl 3 1 imidazolylmethylindole hydrochloride ms 16 056 a new anticonvulsant

Garcia March, F.J.; Garcia Domenech, R.; Galvez, J.; Anton Fos, G.M.; D.J.lian Ortiz, J.V.; Giner Pons, R.; Recio Iglesias, M.C., 1997:
Pharmacological studies of 1- propanol as 2- phenol Two new non-narcotic analgesics designed by molecular connectivity

Otsu, T.; Kawabata, H.; Shimizu, H.; Horikomi, K.; Mizuchi, A.; Matsubara, A., 1990:
Pharmacological studies of 3 phenyl 5 2 pyrrolidinomethylbutyrylisoxazole hydrochloride ms 301 a new centrally acting muscle relaxant

Agarwal, S.P.; Prakash, A.; Kohli, K., 1998:
Pharmacological studies of A Kushta Just suspension formulation

Kimura, I.; Nagahama, S.; Kawasaki, M.; Kataoka, M.; Sato, M., 1997:
Pharmacological studies of BX661A, 5- -phenylazo-salicylic acid disodium salt dihydrate

Ashizawa, N.; Yoshida, M.; Sugiyama, Y.; Akaike, N.; Ohbayashi, S.; Aotsuka, T.; Matsuura, A., 1997:
Pharmacological studies of GP-1447, a novel potent aldose reductase inhibitor

Kawamura, K.; Hosotani, T.; Ohashi, T.; Kimura, T.; Watanabe, Y.; Iwanaga, Y.; Morikawa, K.; Kato, H.; Ito, Y.; Gomi, Y., 1995:
Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent 2 Organ specificity of antihistamine action

Musoh, K.; Ohashi, T.; Takahashi, H.; Iwanaga, Y.; Morikawa, K.; Kato, H.; Ito, Y., 1995:
Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent I Effects on various allergic models

Maekawa, Yuriko; Koshiyama, Yoshiko; Kashiwabara, Sanae; Oda, Minoru; Kurumi, Masateru, 1995:
Pharmacological studies of TO-193 -1- Optimal condition for adhesive and sealing effects

Kanno, S.; Kashiwabara, S.; Maekawa, Y.; Muto, T.; Uchiyama, H.; Kariya, K.; Kojima, T.; Ino, Y.; Koshiyama, Y.; Oda, M.; Kurumi, M., 1995:
Pharmacological studies of TO-193 -2- Adhesive and sealing effects on organs and tissues in various experimental models

Ueda, N.; Maekawa, Y.; Kanno, S.; Ohtani, H.; Uchiyama, H.; Kashiwabara, S.; Kojima, K.; Kojima, T.; Koshiyama, Y.; Ino, Y.; Oda, M.; Kurumi, M., 1995:
Pharmacological studies of TO-193 -3- Hemostatic effect on experimental incision models

Yatsugi, S.; Takeuchi, H.; Nakato, K.; Hattori, H.; Koshiya, K.; Fujii, M.; Wanibuchi, F.; Yamaguchi, T., 1994:
Pharmacological studies of YM-35992 A novel selective serotonin re-uptake inhibitor with 5-HT-2 antagonistic activity

Takeuchi, H.; Yatsugi, S.I.hi; Hatanaka, K.I.hi; Nakato, K.; Hattori, H.; Sonoda, R.; Koshiya, K.; Usuda, S.; Fujii, M.; Yamaguchi, T., 1995:
Pharmacological studies of YM-35992, a novel selective 5-HT re-uptake inhibitor with 5-HT2 antagonistic activity

Chaki, H.; Kokuba, Y.; Makita, I.; Sato, M.; Kawashima, M., 1991:
Pharmacological studies of a new amino acid solution mhs 2 for the treatment of hepatic encephalopathy ameliorating effects of mhs 2 on abnormality of neurological status in pca dogs

Kokuba, Y.; Chaki, H.; Makita, I.; Inui, K.; Takechi, Y.; Sato, M.; Kawashima, M., 1991:
Pharmacological studies of a new amino acid solution mhs 2 for the treatment of hepatic encephalopathy influence of branched chain amino acid on brain amine metabolism in pca rats

Matsumoto, J.; Takahashi, T.; Agata, M.; Toyofuku, H.; Sasada, N.; Sawaki, S.; Goto, M., 1992:
Pharmacological studies of a new selective and reversible mao b inhibitor

Gorman, L.K.; Olton, D.S.; Plano, S.; Wenk, G.L., 1990:
Pharmacological studies of acetylcholine release by microdialysis in the freely moving rat

Szczepaniak, W.S.; Moller, A.R., 1996:
Pharmacological studies of activity-dependent inhibition in the inferior colliculus of the rat using a paired-click paradigm A novel mechanism of inhibition in the auditory system?

Hetke, J.F.; BledsoeS.C.Jr.; Chen, J.; Wiler, J.A.; Wise, K.D.; Anderson, D.J., 1995:
Pharmacological studies of amino acid neurotransmitters using silicon substrate drug delivery probes

Chaki, H.; Ichikawa, E.; Kokuba, Y.; Kikuchi, T.; Sato, M., 1993:
Pharmacological studies of an amino acid solution for therapy of hepatic encephalopathy The effect of ammonia metabolism in isolated rat liver perfusion

Sprague, J.E.; Suckow, M.A.; Uetrecht, R.C.; Maickel, R.P., 1993:
Pharmacological studies of analgesia induced by centrifugal swinging of rats

Ness, T.J.; Crimaldi, J., 1997:
Pharmacological studies of analgesics in the acutely spinalized rat

Kokuba, Y.; Chaki, H.; Makita, I.; Inui, K.; Sato, M., 1990:
Pharmacological studies of branched chain amino acid and arginine enriched amino acid solution mhs 2 for the treatment of hepatic encephalopathy effect on the ammonia metabolism in pca rats

Kataoka, M.; Kameda, H.; Takahashi, K.; Kokuba, Y.; Sato, M., 1989:
Pharmacological studies of branched chain amino acid and arginine enriched amino acid solution mhs 2 for the treatment of hepatic failure effects on behavioral and neurotic changes induced by ammonia in rats

Noppen, M.; Vincken, W., 1996:
Pharmacological studies of bronchomotor tone in essential hyperhidrosis before and after thoracoscopic D-2-D-3 sympathicolysis , and in normal subjects

Healy, D.P.; Huo, T.; Bogdanov, V.; Grenader, A., 1993:
Pharmacological studies of dopamine receptors in cultured renal epithelial cells

Suzuki, T., 1989:
Pharmacological studies of drug dependence opioid and cns depressant dependence

Yan, Q.; Matheson, C.R.; Lopez, O.T.; Urich, J.L.; Welcher, A.A.; Collins, F., 1996:
Pharmacological studies of glial cell line-derived neurotrophic factor on adult motoneurons in vivo

Taniguchi, Y.; Furukawa, H.; Deguchi, Y.; Minami, H.; Sakai, M.; Saita, M., 1991:
Pharmacological studies of hai 105 a new non steroidal anti inflammatory and analgesic drug 1 anti inflammatory effect on various animal inflammatory models

Taniguchi, Y.; Deguchi, Y.; Minami, H.; Hamanaka, S.; Saita, M., 1991:
Pharmacological studies of hai 105 a new non steroidal anti inflammatory and analgesic drug 2 analgesic and gastrointestinal ulcerogenic activities

Makino, E.; Ohashi, T.; Takahashi, H.; Kato, H.; Ito, Y.; Nagai, H.; Koda, A.; Azuma, H., 1989:
Pharmacological studies of hsr 6071 a new anti allergic agent

Miyashita, N.; Iwanaga, Y.; Kato K I.; Morikawa, K.; Kato, H.; Ito, Y.; Itoh, Z., 1990:
Pharmacological studies of hsr 803 a novel gastrointestinal prokinetic agent

Hishida, T.; Katayanagi, Y.; Sugiyama, K.; Ono, M.; Nagase, M.; Satoh, T., 1990:
Pharmacological studies of lappaconitine iv changes in blood brain and spinal cord concentrations of lappaconitine in relation to its analgesic activity

Shimada, H.; Isokawa, E.; Iwai, K.; Ono, M.; Nagase, M.; Satoh, T., 1990:
Pharmacological studies of lappaconitine v studies of analgesic action by formalin test in mice

Vibert, N.; Serafin, M.; Khateb, A.; Vidal, P.P.; Muhlethaler, M., 1992:
Pharmacological studies of medial vestibular neurones in guinea pig brainstem slices

Kimura, I.; Furuta, K.; Kamiya, A.; Kataoka, M.; Sato, M., 1989:
Pharmacological studies of mgv 5 a new bowel lavage solution polyethylene glycol electrolyte lavage solution its cleansing effects and influence on electrolytes balance

Kokuba, Y.; Chaki, H.; Makita, I.; Inui, K.; Takechi, Y.; Matsuda, A.; Sato, M.; Kikuchi, T., 1992:
Pharmacological studies of mhs g constituted from bcaa and arginine enriched amino acid granule for hepatic failure effects on electroencephalogram and brain amine metabolism in pca rats

Caulfield, M.P.; Barlow, R.B.; Brown, D.A., 1990:
Pharmacological studies of pre synaptic and post synaptic neuronal nicotinic receptors

Erspamer, V.; Erspamer, G.F.lconieri; Severini, C.; Potenza, R.L.isa; Barra, D.; Mignogna, G.; Bianchi, A., 1993:
Pharmacological studies of sapo from the frog Phyllomedusa bicolor skin A drug used by the Peruvian Matses Indians in shamanic hunting practices

Buckner, C.K.; Ghanekar, S.V.; Kays, J.S.; Krell, R.D., 1991:
Pharmacological studies of tachykinin receptors mediating contraction of hamster trachea

Buckner, C.K.; Ghanekar, S.V.; Kays, J.S.; Krell, R.D.; Fishleder, R.I.; Will, J.A.; Vann, J.M., 1991:
Pharmacological studies of tachykinin receptors mediating contraction of isolated airway smooth muscle

Sisken, J.E.; Newcomb, T.G.; Mullins, R.D., 1994:
Pharmacological studies of the exaggerated capacitative Ca-2+ entry mechanism in SV40-transformed Swiss 3T3 cells

Goddard, J.G.; Kontoghiorghes, G.J., 1990:
Pharmacological studies of the orally active iron chelator 1 2 dimethyl 3 hydroxypyrid 4 one l1 in man

Sileniece, G.; Rudzite, V., 1996:
Pharmacological studies of the role of kynurenine in the heart pathology

Matuszek, M.A.; Hodgson, W.C.; Sutherland, S.K.; King, R.G., 1994:
Pharmacological studies of the venom of an Australian bulldog ant

Truex, L.L.; Foreman, M.M., 1989:
Pharmacological studies of various agents on potassium evoked release of tritiated norepinephrine t ne from rat corpora cavernosa

Shepherd, A.M.M.; Carberry, P.A.; Bennett, C.; Scholler, I.; Stevenson, I.H., 1992:
Pharmacological studies of vascular structure and function in hypertension

Sakitama, K.; Ozawa, Y.; Aoto, N.; Komai, C.; Kojima, Y.; Ishikawa, M.; Shiozawa, A., 1990:
Pharmacological studies on 2r levo 2 methyl 3 pyrrolidino 1 4 trifluoromethylphenyl 1 propanone hydrochloride nk 433 a new centrally acting muscle relaxant

Sakitama, K.; Ozawa, Y.; Aoto, N.; Ishikawa, M.; Shiozawa, A., 1989:
Pharmacological studies on 2r levo 2 methyl 3 pyrrolidino 1 4 trifluoromethylphenylpropanone hydrochloride nk 433 a new centrally acting muscle relaxant

Ozawa, Y.; Sakitama, K.; Kojima, Y.; Aoto, N.; Komai, C.; Ishikawa, M., 1990:
Pharmacological studies on 2r levo 2 methyl 3 pyrrolidino 1 4 trifluoromethylphenylpropanone hydrochloride nk 433 a new centrally acting muscle relaxant 2 effect on motor systems

Oka, Motoo, 1996:
Pharmacological studies on Ca-2+-dependent exocytosis in adrenal chromaffin cells

Chang, T.; Zhang, K.; Li, J., 1998:
Pharmacological studies on China-made zopiclone

Takahashi, H.; Ohashi, T.; Kato, K.I.hi; Iwanaga, Y.; Morikawa, K.; Kato, H.; Ito, Y., 1995:
Pharmacological studies on HSR-284, a novel hybrid eicosanoid antagonist

Ishii, H.; Sakaki, Y.; Ikemura, T.; Kitamura, S.; Ohmori, K., 1995:
Pharmacological studies on KW-4679, an antiallergic drug Inhibitory effect on passive cutaneous anaphylaxis and experimental asthma in rats and guinea pigs

Hamamoto, T.; Kato, M.; Miaki, Y.; Shoji, N.; Tamaoki, H.; Yoshii, E., 1998 :
Pharmacological studies on LCY-018, a novel nonpeptide angiotensin II receptor antagonist

Tsuda, T.; Sugaya, A.; Kaneko, E.; Ohguchi, H.; Katoh, K.; Jin, W.; Sugaya, E., 1998:
Pharmacological studies on Longgu and oyster shell

Nakagawa, S.; Aoki, T.; Suzuki, H.; Tamaki, T.; Wada, Y.; Yokoo, N.; Kitahara, M.; Saito, Y., 1995:
Pharmacological studies on NK-104, a novel potent HMG-CoA reductase inhibitor Inhibitory effects on the enzyme and sterol synthesis in rats and hypolipidemic effects in dogs

Aoki, T.; Nakagawa, S.; Suzuki, H.; Tamaki, T.; Wada, Y.; Yokoo, N.; Kitahara, M.; Saito, Y., 1995:
Pharmacological studies on NK-104, a novel potent HMG-CoA reductase inhibitor Plasma lipid-lowering effects in guinea pigs